Cinemark (CNK) 10-Q 5 Nov 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2020	Oct. 30, 2020
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Entity Registrant Name	CINEMARK HOLDINGS, INC.
Entity Central Index Key	0001385280
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		118,158,433
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	false
Entity File Number	001-33401
Entity Tax Identification Number	20-5490327
Entity Address, Address Line One	3900 Dallas Parkway
Entity Address, City or Town	Plano
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75093
City Area Code	972
Local Phone Number	665-1000
Entity Incorporation, State or Country Code	DE
Document Quarterly Report	true
Document Transition Report	false
Title of Each Class	Common stock, par value $.001 per share
Trading Symbol(s)	CNK
Name of each exchange on which registered	NYSE

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 825,706	$ 488,313
Inventories	15,159	21,686
Accounts receivable	24,645	83,722
Current income tax receivable	84,105	4,082
Prepaid expenses and other	34,394	37,187
Total current assets	984,009	634,990
Theatre properties and equipment	3,252,987	3,348,237
Less: accumulated depreciation and amortization	1,707,164	1,612,990
Theatre properties and equipment, net	1,545,823	1,735,247
Operating lease right-of-use assets, net	1,286,224	1,383,080
Other assets
Goodwill	1,249,427	1,283,371	[1]
Intangible assets, net	315,569	321,769
Investments in affiliates	118,589	155,285
Long-term deferred tax asset	16,491	9,369
Deferred charges and other assets, net	36,047	39,114
Total other assets	1,986,557	2,074,700
Total assets	5,802,613	5,828,017
Current liabilities
Current portion of long-term debt	7,965	6,595
Current portion of operating lease obligations	216,382	217,406
Current portion of finance lease obligations	16,224	15,432
Current income tax payable	0	5,195
Current liability for uncertain tax positions	0	13,446
Accounts payable and accrued expenses	383,306	450,726
Total current liabilities	623,877	708,800
Long-term liabilities
Long-term debt, less current portion	2,366,380	1,771,342
Operating lease obligations, less current portion	1,137,822	1,223,462
Finance lease obligations, less current portion	128,727	141,017
Long-term deferred tax liability	103,906	141,836
Long-term liability for uncertain tax positions	14,678	848
Other long-term liabilities	62,538	44,036
Total long-term liabilities	4,160,288	3,670,895
Commitments and contingencies (see Note 19)	0	0
Cinemark Holdings, Inc.'s stockholders' equity:
Common stock, $0.001 par value: 300,000,000 shares authorized, 123,029,693 shares issued and 118,161,153 shares outstanding at September 30, 2020 and 121,863,515 shares issued and 117,151,656 shares outstanding at December 31, 2019	123	122
Additional paid-in-capital	1,238,547	1,170,039
Treasury stock, 4,868,540 and 4,711,859 shares, at cost, at September 30, 2020 and December 31, 2019, respectively	(84,432)	(81,567)
Retained earnings	267,193	687,332
Accumulated other comprehensive loss	(414,398)	(340,112)
Total Cinemark Holdings, Inc.'s stockholders' equity	1,007,033	1,435,814
Noncontrolling interests	11,415	12,508
Total equity	1,018,448	1,448,322
Total liabilities and equity	5,802,613	5,828,017
NCM
Other assets
Investment in NCM	250,434	265,792
Long-term liabilities
NCM screen advertising advances	$ 346,237	$ 348,354
[1]	Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2020	Dec. 31, 2019
Statement Of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	123,029,693	121,863,515
Common stock, shares outstanding	118,161,153	117,151,656
Treasury stock, shares	4,868,540	4,711,859

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Revenues
Total revenues		$ 35,478	$ 821,817	$ 588,068	$ 2,494,296
Cost of operations
Film rentals and advertising		8,257	254,911	165,262	759,693
Concession supplies		2,688	51,573	39,879	157,361
Salaries and wages		20,181	103,270	116,589	308,316
Facility lease expense		67,047	87,436	214,490	262,529
Utilities and other		43,412	123,877	178,806	357,210
General and administrative expenses		30,342	44,702	99,361	127,002
Depreciation and amortization		62,543	67,760	191,380	196,795
Impairment of long-lived assets		24,595	27,304	41,214	45,382
Restructuring costs		524		20,062
(Gain) loss on disposal of assets and other		(13,327)	2,453	(10,997)	8,057
Total cost of operations		246,262	763,286	1,056,046	2,222,345
Operating income (loss)		(210,784)	58,531	(467,978)	271,951
Other income (expense)
Interest expense	[1]	(36,577)	(24,967)	(92,284)	(75,037)
Interest income		1,348	3,903	4,235	10,062
Foreign currency exchange loss		(2,251)	(4,406)	(6,183)	(4,785)
Equity in income (loss) of affiliates		(16,077)	15,139	(27,711)	33,982
Total other expense		(58,397)	(12,523)	(132,694)	(40,790)
Income (loss) before income taxes		(269,181)	46,008	(600,672)	231,161
Income taxes		(121,145)	14,053	(222,398)	64,152
Net income (loss)		(148,036)	31,955	(378,274)	167,009
Less: Net income (loss) attributable to noncontrolling interests		(444)	602	(702)	1,957
Net income (loss) attributable to Cinemark Holdings, Inc.		$ (147,592)	$ 31,353	$ (377,572)	$ 165,052
Weighted average shares outstanding
Basic		116,707	116,356	116,552	116,288
Diluted		116,707	116,600	116,552	116,577
Earnings (loss) per share attributable to Cinemark Holdings, Inc.'s common stockholders
Basic		$ (1.25)	$ 0.27	$ (3.22)	$ 1.41
Diluted		$ (1.25)	$ 0.27	$ (3.22)	$ 1.41
NCM
Other income (expense)
Distributions from NCM		$ 1,061	$ 2,474	$ 6,975	$ 9,168
Interest expense - NCM		(5,901)	(4,666)	(17,726)	(14,180)
Admissions
Revenues
Total revenues		14,901	454,429	307,400	1,371,041
Concession
Revenues
Total revenues		9,116	289,477	199,596	886,083
Other
Revenues
Total revenues		$ 11,461	$ 77,911	$ 81,072	$ 237,172
[1]	Includes amortization of debt issue costs and amortization of accumulated losses for amended swap agreements.

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Statement Of Income And Comprehensive Income [Abstract]
Net income (loss)	$ (148,036)	$ 31,955	$ (378,274)	$ 167,009
Other comprehensive income (loss), net of tax
Unrealized gain (loss) due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements	6,528	(1,291)	(16,794)	(10,504)
Other comprehensive loss in equity method investments	0	(49)	0	(142)
Foreign currency translation adjustments	(1,503)	(25,408)	(62,830)	(19,728)
Total other comprehensive loss, net of tax	5,025	(26,748)	(79,624)	(30,374)
Total comprehensive income (loss), net of tax	(143,011)	5,207	(457,898)	136,635
Comprehensive (income) loss attributable to noncontrolling interests	444	(602)	702	(1,957)
Comprehensive income (loss) attributable to Cinemark Holdings, Inc.	$ (142,567)	$ 4,605	$ (457,196)	$ 134,678

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Statement Of Income And Comprehensive Income [Abstract]
Unrealized loss due to fair value adjustments on interest rate swap agreements, taxes	$ 5,677	$ 417	$ 3,696	$ 3,391

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Operating activities
Net income (loss)	$ (148,036)	$ 31,955	$ (378,274)	$ 167,009
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:
Depreciation			187,748	193,032
Amortization of intangible and other assets			3,632	3,763
Amortization of debt issue costs			4,942	3,983
Non-cash accretion on convertible notes			1,739
Interest accrued on NCM screen advertising advances			(17,726)
Amortization of accumulated losses for amended swap agreements			5,338
Impairment of long-lived assets	24,595	27,304	41,214	45,382
Share based awards compensation expense	4,427	3,840	12,859	10,486
(Gain) loss on disposal of assets and other			(10,997)	8,057
Non-cash rent expense	816	(1,102)	1,649	(3,252)
Equity in (income) loss of affiliates	16,077	(15,139)	27,711	(33,982)
Deferred income tax expenses			(29,941)	(5,314)
Distributions from equity investees			25,430	28,163
Changes in assets and liabilities and other			(54,782)	(7,909)
Net cash provided by (used for) operating activities			(167,653)	397,215
Investing activities
Additions to theatre properties and equipment	(20,659)	(71,343)	(67,618)	(186,512)
Acquisition of U.S. theatres, net of cash acquired				(10,170)
Proceeds from sale of theatre properties and equipment and other			212	377
Investment in joint ventures and other, net			(50)
Net cash used for investing activities			(67,456)	(196,305)
Financing activities
Dividends paid to stockholders			(42,311)	(119,452)
Payroll taxes paid as a result of stock withholdings			(2,865)	(2,247)
Proceeds from convertible notes issued			460,000
Proceeds from other borrowings			257,167
Repayments of long-term debt			(4,947)	(4,947)
Payment of debt issue costs			(24,981)
Proceeds from warrants issued			89,424
Payments on finance leases			(11,497)	(10,830)
Other			(392)	(1,588)
Net cash provided by (used for) financing activities			577,504	(139,064)
Effect of exchange rate changes on cash and cash equivalents			(5,002)	(5,296)
Increase in cash and cash equivalents			337,393	56,550
Cash and cash equivalents:
Beginning of period			488,313	426,222
End of period	$ 825,706	$ 482,772	825,706	482,772
Convertible Notes
Financing activities
Purchase of convertible note hedges			(142,094)
NCM
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:
Interest accrued on NCM screen advertising advances			17,726
Amortization of NCM screen advertising advances and other deferred revenues			$ (23,647)	$ (12,203)

The Company and Basis of Presen

The Company and Basis of Presentation	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
The Company and Basis of Presentation	1. The Company and Basis of Presentation The Company and its subsidiaries operate in the motion picture exhibition industry, with theatres in the United States (“U.S.”), Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. The accompanying condensed consolidated balance sheet as of December 31, 2019, which was derived from audited financial statements, and the unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete consolidated financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation have been included. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from these estimates. Majority-owned subsidiaries of which the Company has control are consolidated while those affiliates of which the Company owns between 20% and 50% and does not control are accounted for under the equity method. Those of which the Company owns less than 20% are generally accounted for under the cost method, unless the Company is deemed to have the ability to exercise significant influence over the affiliate, in which case the Company would account for its investment under the equity method. Th These condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and the notes thereto for the year ended December 31, 2019, included in the Annual Report on Form 10-K filed February 21, 2020 by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Operating results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results to be achieved for the full year.

Impact of COVID-19

Impact of COVID-19	9 Months Ended
	Sep. 30, 2020
Extraordinary And Unusual Items [Abstract]
Impact of COVID-19	2. Impact of COVID-19 The outbreak of the COVID-19 pandemic has had an unprecedented impact on the world and the movie exhibition industry. The social and economic effects are widespread, and the situation continues to evolve. As a movie exhibitor that operates spaces where patrons gather in close proximity, the Company has been, and continues to be, significantly impacted by protective actions taken by governmental authorities to control the spread of the pandemic. To comply with government mandates at the initial outbreak of the COVID-19 pandemic, the Company temporarily closed all of its theatres in the U.S. and Latin America effective March 17, 2020 and March 18, 2020, respectively. In conjunction with the temporary closure of its theatres in March 2020, the Company implemented temporary personnel and salary reductions, halted non-essential operating and capital expenditures, and negotiated modified timing and/or abatement of contractual payments with landlords and other major suppliers until its theatres reopened. In addition, the Company suspended its quarterly dividend. As of September 30, 2020, the Company had reopened 252 of its domestic theatres and 15 of its international theatres showing limited volume of new releases along with library content during reduced operating hours. While some staffing has been brought back to pre-COVID-19 levels given the theatre reopenings, the Company continues to maintain a temporary reduction in staffing while limiting capital expenditures to essential activities and projects. The Company also continues to work with landlords and other vendors on extended or modified contractual payment terms while evaluating the status of the COVID-19 pandemic and local government regulations in assessing its plans to reopen its remaining theatres. The Company’s focus on maintaining a healthy balance sheet and low leverage allowed it to enter the global COVID-19 crisis in a strong financial position. Based on the Company’s current level of operations, it believes that it has sufficient cash to sustain operations until late 2021, which would extend into 2022 when considering the additional income tax benefits discussed below. Nonetheless, the COVID-19 pandemic has had, and may continue to have, adverse effects on the Company’s business, results of operations, cash flows, financial condition, access to credit markets and ability to service existing and future indebtedness, some of which may be significant. Health and Safety Protocols The Company has implemented health and safety protocols in its theatres as a result of the pandemic for the safety of its employees and guests including, but not limited to, the following: • staggering showtimes and limiting capacities to maximize physical distancing • instituting a seat buffering technology to ensure social distancing within the auditorium • requiring face masks for all guests within the theater, which may only be removed for eating and drinking in the auditoriums • implementing stringent disinfecting and sanitizing protocols and providing ample supplies of hand sanitizer and seat wipes for patrons • delivering an abundant supply of fresh outdoor air, maintaining optimal air circulation and eliminating potential pollutants through filtration • encouraging contactless transactions • requiring that employees receive special training, participate in wellness check-ins and use personal protective wear, including face masks and gloves With these comprehensive health and safety protocols in place, we believe we can more safely operate theaters while prioritizing the health of employees, guests and communities. The Company will continue to evolve these protocols based on changes to recommendations by local authorities throughout the region, as well as based on the Company’s experience as it reopens theatres domestically and throughout Latin America. Restructuring Charges In addition to the Company’s initial actions in response to the COVID-19 pandemic discussed above, during June 2020, Company management approved and announced a restructuring plan to realign its operations creating a more efficient cost structure (referred to herein as the “2020 Restructuring Plan”). The 2020 Restructuring Plan primarily includes a permanent headcount reduction at its domestic corporate office and the permanent closure of 14 domestic and 7 international theatres. The Company recorded $524 and $20,062 in restructuring costs on the condensed consolidated statement of income for the three and nine months ended September 30, 2020, respectively. The following table summarizes the costs of the 2020 Restructuring Plan, payments made, noncash write-offs and the remaining liability at September 30, 2020: U.S. Operating Segment International Operating Segment Consolidated Employee-related Costs Facility Closure Costs Total Charges Employee-related Costs Facility Closure Costs Total Charges Employee-related Costs Facility Closure Costs Total Charges Restructuring charges during the three months ended June 30, 2020 $ 8,955 $ 7,589 $ 16,544 $ 163 $ 2,831 $ 2,994 $ 9,118 $ 10,420 $ 19,538 Amounts paid (90 ) (482 ) (572 ) — (42 ) (42 ) (90 ) (524 ) (614 ) Noncash write-offs — 88 88 — (2,374 ) (2,374 ) — (2,286 ) (2,286 ) Reserve balance at June 30, 2020 $ 8,865 $ 7,195 $ 16,060 $ 163 $ 415 $ 578 $ 9,028 $ 7,610 $ 16,638 Restructuring charges during the three months ended September 30, 2020 (1) — 154 154 17 353 370 17 507 524 Amounts paid (6,521 ) (436 ) (6,957 ) (180 ) (313 ) (493 ) (6,701 ) (749 ) (7,450 ) Noncash write-offs — 47 47 — (129 ) (129 ) — (82 ) (82 ) Reserve balance at September 30, 2020 $ 2,344 $ 6,960 $ 9,304 $ — $ 326 $ 326 $ 2,344 $ 7,286 $ 9,630 The unpaid and accrued restructuring costs of $9,630 are reflected in accounts payable and accrued expenses on the condensed consolidated balance sheet as of September 30, 2020. Income Tax Considerations The Company has elected to take advantage of certain tax-related benefits available under the Coronavirus Aid, Relief, and Economic Security Act of 2020 (the “CARES Act”) signed into U.S. federal law on March 27, 2020. The CARES Act, among other things, includes provisions relating to refundable payroll tax credits, deferment of employer social security payments, net operating loss (“NOL”) utilization and carryback periods, modifications to the net interest deduction limitations and a technical correction to the 201 7 Tax Cuts and Jobs Act, which makes certain qualified improvement property eligible for bonus depreciation. Per the provisions of the CARES Act, the Company has deferred payment of certain employer payroll taxes for 2020 and has recorded payroll tax credi ts for expenses related to paying wages and health benefits to employees who were not working as a result of closures and reduced receipts associated with COVID-19. An income tax benefit of $(121,145) was recorded for the third quarter of 2020 compared to income tax expense of $14,053 for the third quarter of 2019 on book (loss)/income of $(269,181) and $46,008, respectively. The effective tax rate was approximately 45.0% for the third quarter of 2020 compared to 30.5% for the third quarter of 2019. The Company’s 2020 effective tax rate was positively impacted by provisions in the CARES Act that allow for net operating losses originating in 2018, 2019 or 2020 to be carried back to earlier tax years, many of which had a 35% corporate tax rate. As a result of the pandemic, Cinemark has incurred significant U.S. losses, which the Company is carrying back to prior years. The Company recorded an income tax benefit of $(222,398) for the nine months ended September 30, 2020 with regard to U.S. operating losses, tax losses with respect to investments in foreign subsidiaries and a write down of certain intercompany receivables associated with the Company’s foreign subsidiaries. The Company has recorded an income tax receivable of $84,105 as of September 30, 2020 and received cash tax refunds of $115,769 during the nine months ended September 30, 2020. If the Company receives certain government disaster relief assistance, it may be subject to certain requirements imposed by the government on the recipients of the aid including restrictions on executive officer compensation, share buybacks, dividends, prepayment of debt, incurrence of additional indebtedness and other similar restrictions until the aid is repaid or redeemed in full. However, the Company cannot predict the manner in which such benefits will be allocated or administered and cannot predict whether it will be able to access such benefits in a timely manner or at all.

New Accounting Pronouncements

New Accounting Pronouncements	9 Months Ended
	Sep. 30, 2020
Accounting Changes And Error Corrections [Abstract]
New Accounting Pronouncements	3. New Accounting Pronouncements ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity

Lease Accounting

Lease Accounting	9 Months Ended
	Sep. 30, 2020
Leases [Abstract]
Lease Accounting	4. Lease Accounting Lease Deferrals and Abatements Upon the temporary closure of theatres in March 2020, the Company initiated discussions with landlords to negotiate the deferral of rent and other lease-related payments while theatres remained closed. These discussions and negotiations have remained ongoing as the Company continues to be impacted by the COVID-19 pandemic. The amendments signed with the landlords involve varying concessions, including the abatement of rent payments during closure, deferral of all or a portion of rent payments to later periods and deferrals of rent payments to later periods combined with an early exercise of an existing renewal option or extension of the lease term. In some cases, the Company is entitled to rent-free periods while theatres remain closed in certain locations due to local regulations. Total payments deferred as of September 30, 2020 were approximately $62,559 and are included in accounts payable and accrued expenses in the condensed consolidated balance sheet. In April 2020, the FASB staff released guidance indicating that in response to the COVID-19 crisis, an entity would not have to analyze each contract to determine whether enforceable rights and obligations for concessions exist in the contract and can elect to apply or not apply the lease modification guidance in Topic 842 to those contracts. The election is available for concessions related to the effects of the COVID-19 pandemic that do not result in a substantial increase in the rights of the lessor or the obligations of the lessee. For example, this election is available for concessions that result in the total payments required by the modified contract being substantially the same as or less than total payments required by the original contract. The Company elected to not remeasure the related lease liabilities and right-of-use assets for those leases where the concessions and deferrals did not result in a significant change in total payments under the lease and where the remaining lease term did not change as a result of the negotiation. For those leases that were renewed or extended as a result of the negotiation to defer rent payments, the Company recalculated the related lease liability and right-of-use asset based on the new terms. During the three and nine months ended September 30, 2020, the Company did not recognize a material amount of negative lease expense related to rent abatement concessions. The following table represents the Company’s aggregate lease costs, by lease classification, for the periods presented. Three Months Ended Nine Months Ended September 30 September 30 Lease Cost Classification 2020 2019 2020 2019 Operating lease costs Equipment (1) Utilities and other $ 823 $ 1,569 $ 2,495 $ 5,173 Real Estate (2)(3) Facility lease expense 65,970 88,149 211,088 262,783 Total operating lease costs $ 66,793 $ 89,718 $ 213,583 $ 267,956 Finance lease costs Amortization of leased assets Depreciation and amortization $ 3,665 $ 3,703 $ 11,052 $ 11,182 Interest on lease liabilities Interest expense 1,725 1,922 5,333 5,927 Total finance lease costs $ 5,390 $ 5,625 $ 16,385 $ 17,109 (1) Includes approximately $(267) and $452 of short-term lease payments for the three months ended September 30, 2020 and 2019, respectively. Includes approximately $(839) and $1,808 of short-term lease payments for the nine months ended September 30, 2020 and 2019, respectively. The amounts for the three and nine months ended September 30, 2020 were impacted by i) a decrease in short term lease payments while theatres were closed and ii) rent abatements on leases that were not recalculated in accordance with the FASB guidance discussed above, which resulted in variable rent credits in the amount of the rent abatements. (2) Includes approximately $(191) and $18,591 of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenues or attendance and variable common area maintenance costs for the three months ended September 30, 2020 and 2019, respectively. Includes approximately $9,146 and $54,209 of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenues or attendance and variable common area maintenance costs for the nine months ended September 30, 2020 and 2019. The amounts for the three and nine months ended September 30, 2020 were impacted by rent abatements on leases that were not recalculated in accordance with the FASB guidance discussed above, which resulted in variable rent credits in the amount of the rent abatements. (3) Approximately $335 and $400 of lease payments are included in general and administrative expenses primarily related to office leases for the three months ended September 30, 2020 and 2019, respectively. Approximately $1,122 and $1,184 of lease payments are included in general and administrative expenses primarily related to office leases for the nine months ended September 30, 2020 and 2019, respectively. The following table represents the minimum cash lease payments included in the measurement of lease liabilities and the non-cash addition of assets for the periods indicated. Nine Months Ended September 30, Other Information 2020 2019 Contractual cash payments included in the measurement of lease liabilities (1) Cash outflows for operating leases $ 205,276 $ 211,940 Cash outflows for finance leases - operating activities $ 5,304 $ 5,756 Cash outflows for finance leases - financing activities $ 11,497 $ 10,830 Non-cash amount of leased assets obtained in exchange for: Operating lease liabilities - real estate $ 84,209 $ 53,526 Operating lease liabilities - equipment $ 32 $ 668 Finance lease liabilities $ — $ — (1) As discussed above at Lease Deferrals and Abatements As of September 30, 2020, the Company had signed lease agreements with total noncancelable lease payments of approximately $220,417 related to theatre leases that had not yet commenced. The timing of lease commencement is dependent on the completion of construction of the related theatre facility. Additionally, these amounts are based on estimated square footage and costs to construct each facility and may be subject to adjustment upon final completion of each construction project. In accordance with ASC Topic 842, fixed minimum lease payments related to these theatres are not included in the right-of-use assets and lease liabilities as of September 30, 2020. There were no noncancelable lease agreements signed, but not yet commenced, related to equipment leases as of September 30, 2020.

Revenue Recognition

Revenue Recognition	9 Months Ended
	Sep. 30, 2020
Revenue From Contract With Customer [Abstract]
Revenue Recognition	5. Revenue Recognition The Company’s patrons have the option to purchase movie tickets well in advance of a movie showtime or right before the movie showtime, or at any point in between those two timeframes depending on seat availability. The Company recognizes such admissions revenues when the showtime for a purchased movie ticket has passed. Concession revenues are recognized when products are sold to the consumer. Other revenues primarily consist of screen advertising and screen rental revenues, promotional income, studio trailer placements and transactional fees. The Company sells gift cards and discount ticket vouchers, the proceeds from which are recorded as deferred revenues. Deferred revenues for gift cards and discount ticket vouchers are recognized when they are redeemed for concession items or, if redeemed for movie tickets, when the showtime has passed. The Company offers a subscription program in the U.S. whereby patrons can pay a monthly fee to receive a monthly credit for use towards a future movie ticket purchase. The Company records the monthly subscription program fees as deferred revenues and records admissions revenues when the showtime for a movie ticket purchased with a credit has passed. The Company has loyalty programs in the U.S. and many of its international locations that either have a prepaid annual membership fee or award points to customers as purchases are made. For those loyalty programs that have an annual membership fee, the Company recognizes the fee collected as other revenues on a straight-line basis over the term of the membership. For those loyalty programs that award points to customers based on their purchases, the Company records a portion of the original transaction proceeds as deferred revenues based on the number of reward points issued to customers and recognizes the deferred revenues when the customer redeems such points. The value of loyalty points issued is based on the estimated fair value of the rewards offered. The Company records breakage revenue on gift cards and discount ticket vouchers generally based on redemption activity and historical experience with unused balances. The Company records breakage revenue upon the expiration of loyalty points and subscription credits. Advances collected on concession and other contracts are deferred and recognized during the period in which the Company satisfies the related performance obligations, which may differ from the period in which the advances are collected. These advances are recognized on either a straight-line basis over the term of the contracts or as the Company meets its performance obligations in accordance with the terms of the contracts. Accounts receivable as of September 30, 2020 and December 31, 2019 included approximately $6,162 and $31,620 of receivables, respectively, related to contracts with customers. The Company did not record any assets related to the costs to obtain or fulfill a contract with customers during the nine months ended September 30, 2020 or September 30, 2019. Disaggregation of Revenue The following tables present revenues for the three and nine months ended September 30, 2020 and 2019, disaggregated based on major type of good or service and by reportable operating segment and disaggregated based on timing of revenue recognition. Three Months Ended Nine Months Ended September 30, 2020 September 30, 2020 U.S. International U.S. International Operating Operating Operating Operating Major Goods/Services Segment (1) Segment Consolidated Segment (1) Segment Consolidated Admissions revenues $ 14,794 $ 107 $ 14,901 $ 247,157 $ 60,243 $ 307,400 Concession revenues 8,861 255 9,116 161,674 37,922 199,596 Screen advertising, screen rental and promotional revenues (2) 9,227 513 9,740 35,319 13,437 48,756 Other revenues 1,527 194 1,721 25,857 6,459 32,316 Total revenues $ 34,409 $ 1,069 $ 35,478 $ 470,007 $ 118,061 $ 588,068 Three Months Ended Nine Months Ended September 30, 2019 September 30, 2019 U.S. International U.S. International Operating Operating Operating Operating Major Goods/Services Segment (1) Segment Consolidated Segment (1) Segment Consolidated Admissions revenues $ 351,122 $ 103,307 $ 454,429 $ 1,066,884 $ 304,157 $ 1,371,041 Concession revenues 230,415 59,062 289,477 704,727 181,356 886,083 Screen advertising, screen rental and promotional revenues 21,114 16,448 37,562 63,996 49,587 113,583 Other revenues 30,394 9,955 40,349 95,180 28,409 123,589 Total revenues $ 633,045 $ 188,772 $ 821,817 $ 1,930,787 $ 563,509 $ 2,494,296 Three Months Ended Nine Months Ended September 30, 2020 September 30, 2020 U.S. International U.S. International Operating Operating Operating Operating Timing of Recognition Segment (1) Segment Consolidated Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 24,945 $ 352 $ 25,297 $ 426,476 $ 101,681 $ 528,157 Goods and services transferred over time (2) 9,464 717 10,181 43,531 16,380 59,911 Total $ 34,409 $ 1,069 $ 35,478 $ 470,007 $ 118,061 $ 588,068 Three Months Ended Nine Months Ended September 30, 2019 September 30, 2019 U.S. International U.S. International Operating Operating Operating Operating Timing of Recognition Segment (1) Segment Consolidated Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 610,063 $ 169,171 $ 779,234 $ 1,860,828 $ 504,702 $ 2,365,530 Goods and services transferred over time 22,982 19,601 42,583 69,959 58,807 128,766 Total $ 633,045 $ 188,772 $ 821,817 $ 1,930,787 $ 563,509 $ 2,494,296 (1) U.S. segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 17 for additional information on intercompany eliminations. (2) Amount includes amortization of NCM screen advertising advances. See Deferred Revenues Deferred Revenues The following table presents changes in the Company’s advances and deferred revenues for the nine months ended September 30, 2020. NCM screen advertising advances (1) Other Deferred Revenues (2) Total Balance at January 1, 2020 $ 348,354 $ 138,426 $ 486,780 Amounts recognized as accounts receivable — 2,788 2,788 Cash received from customers in advance — 45,933 45,933 Common units received from NCM (see Note 9) 3,620 — 3,620 Interest accrued related to significant financing component 17,726 — 17,726 Revenue recognized during period (23,463 ) (44,714 ) (68,177 ) Foreign currency translation adjustments — (2,022 ) (2,022 ) Balance at September 30, 2020 $ 346,237 $ 140,411 $ 486,648 (1) See Note 9 for the maturity of balance as of September 30, 2020. (2) Includes liabilities associated with outstanding gift cards and discount ticket vouchers, points or rebates outstanding under the Company’s loyalty and membership programs and revenues not yet recognized for screen advertising, screen rental and other promotional activities. Classified as accounts payable and accrued expenses or other long-term liabilities on the condensed consolidated balance sheet. The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of September 30, 2020 and when the Company expects to recognize this revenue. Twelve Months Ended September 30, Remaining Performance Obligations 2021 2022 2023 2024 2025 Thereafter Total Other Deferred revenue $ 125,429 $ 14,936 $ 46 $ — $ — $ — $ 140,411

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2020
Earnings Per Share [Abstract]
Earnings Per Share	6. Earnings Per Share The Company considers its unvested share-based payment awards, which contain non-forfeitable rights to dividends, participating securities, and includes such participating securities in its computation of earnings per share pursuant to the two-class method. Basic earnings per share for the two classes of stock (common stock and unvested restricted stock) is calculated by dividing net income by the weighted average number of shares of common stock and unvested restricted stock outstanding during the reporting period. Diluted earnings per share is calculated using the weighted average number of shares of common stock plus the potentially dilutive effect of common equivalent shares outstanding determined under both the two-class method and the treasury stock method. The following table presents computations of basic and diluted earnings per share under the two-class method: Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Numerator: Net income (loss) attributable to Cinemark Holdings, Inc. $ (147,592 ) $ 31,353 $ (377,572 ) $ 165,052 Loss (earnings) allocated to participating share-based awards (1) 1,472 (211 ) 2,832 (1,012 ) Net income (loss) attributable to common stockholders $ (146,120 ) $ 31,142 $ (374,740 ) $ 164,040 Denominator (shares in thousands): Basic weighted average common stock outstanding 116,707 116,356 116,552 116,288 Common equivalent shares for restricted stock units (2) — 244 — 289 Diluted common equivalent shares 116,707 116,600 116,552 116,577 Basic earnings (loss) per share attributable to common stockholders $ (1.25 ) $ 0.27 $ (3.22 ) $ 1.41 Diluted earnings (loss) per share attributable to common stockholders $ (1.25 ) $ 0.27 $ (3.22 ) $ 1.41 (1) For the three months ended September 30, 2020 and 2019, a weighted average of approximately 1,175 and 793 shares of restricted stock, respectively, were considered participating securities. (2) For the three months ended September 30, 2020, approximately 438 common equivalent shares for restricted stock units were excluded because they were anti-dilutive. For the nine months ended September 30, 2020, approximately 689 common equivalent shares for restricted stock units were excluded because they were anti-dilutive. The calculations of diluted earnings per share for the three and nine months ended September 30, 2020 do not include the impact of the conversion of the 4.50% Convertible Senior Notes, issued August 21, 2020, into 32,051,282 shares of common stock, as it would be anti-dilutive. Additionally, the average price of the Company’s common stock did not exceed $22.08 per share during the reporting period; therefore, additional shares that may be issued related to the recently issued warrants were not included in the calculation of diluted common equivalent shares. See further discussion of the 4.50% Convertible Senior Notes, the convertible note hedges and the warrants at Note 7.

Long Term Debt Activity

Long Term Debt Activity	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Long Term Debt Activity	7. Long Term Debt Activity Senior Secured Credit Facility Cinemark USA, Inc. has a senior secured credit facility that includes a $700,000 term loan and a $100,000 revolving credit line (the “Credit Agreement”). On March 25, 2020, the Company borrowed $98,800 under the revolving credit line of the Credit Agreement, which was repaid on September 30, 2020. As of September 30, 2020, there was $641,381 outstanding under the term loan and no borrowings were outstanding under the revolving credit line. As of September 30, 2020, approximately $100,000 was available for borrowing under the revolving credit line. Quarterly principal payments of $1,649 are due on the term loan through December 31, 2024, with a final principal payment of $613,351 due on March 29, 2025. The revolving credit line matures November 28, 2022. The average interest rate applicable to outstanding term loan borrowings under the Credit Agreement at September 30, 2020 was approximately 3.4 % per annum, after giving effect to the interest rate swap agreements discussed below. On April 17, 2020, in conjunction with the issuance of the 8.750% Secured Notes discussed below, the Company obtained a waiver of the leverage covenant, which applies when amounts are outstanding under the revolving line of credit, from the majority of revolving lenders under the Credit Agreement for the fiscal quarters ending September 30, 2020 and December 31, 2020. On August 21, 2020, in conjunction with the issuance of the 4.50% Convertible Senior Notes discussed below, the Company further amended the waiver of the leverage covenant to extend through the fiscal quarter ending September 30, 2021. The amendment also (i) modifies the leverage covenant calculation beginning with the calculation for the trailing twelve-month period ended December 31, 2021, (ii) for purposes of testing the consolidated net senior secured leverage ratio for the fiscal quarters ending on December 31, 2021, March 31, 2022 and June 30, 2022, permits the Company to substitute Consolidated EBITDA for the first three fiscal quarters of 2019 in lieu of Consolidated EBITDA for the corresponding fiscal quarters of 2021, (iii) modifies the restrictions imposed by the covenant waiver, and (iv) makes such other changes to permit the issuance of the 4.50% Convertible Senior Notes discussed below. 8.750% Secured Notes On April 20, 2020, Cinemark USA, Inc. issued $250,000 8.750% senior secured notes (the “8.750% Secured Notes”). The 8.750% Secured Notes will mature on May 1, 2025; provided, however, that if (i) on September 13, 2022, the aggregate outstanding principal amount of the 5.125% Senior Notes that shall not have been purchased, repurchased, redeemed, defeased or otherwise acquired, retired, cancelled or discharged exceeds $50,000, the 8.750% Secured Notes will mature on September 14, 2022 and (ii) on February 27, 2023, the aggregate outstanding principal amount of the 4.875% Senior Notes that shall not have been purchased, repurchased, redeemed, defeased or otherwise acquired, retired, cancelled or discharged exceeds $50,000, the 8.750% Secured Notes will mature on February 28, 2023. Interest on the 8.750% Secured Notes will be payable on May 1 and November 1 of each year, beginning on November 1, 2020. The 8.750% Secured Notes will be fully and unconditionally guaranteed on a joint and several senior basis by certain of the Company’s subsidiaries that guarantee, assume or in any other manner become liable with respect to any of the Company’s or its guarantors’ other debt. If the Company cannot make payments on the 8.750% Secured Notes when they are due, the Company’s guarantors must make them instead. Under certain circumstances, the guarantees may be released without action by, or the consent of, the holders of the 8.750% Secured Notes. The 8.750% Secured Notes and the guarantees will be the Company’s and its guarantors’ senior obligations and they will: • rank effectively senior in right of payment to the Company’s and its guarantors’ existing and future debt that is not secured by the collateral as described within the indentures to the 8.750% Secured Notes (“Collateral”), including all obligations under the Credit Agreement, and unsecured obligations, including the existing senior notes, in each case to the extent of the value of the collateral; • rank effectively junior to the Company’s and its guarantors’ existing and future debt secured by assets that are not part of the Collateral to the extent of the value of the collateral securing such debt, including all obligations under the Credit Agreement; • otherwise rank equally in right of payment to the Company’s and its guarantors’ existing and future senior debt, including debt under the Credit Agreement and the existing senior notes; • rank senior in right of payment to the Company’s and its guarantors’ future subordinated debt; and • be structurally subordinated to all existing and future debt and other liabilities of the Company’s non-guarantor subsidiaries. The indenture to the 8.750% Secured Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. Upon a change of control, as defined in the indenture governing the 8.750% Secured Notes, Cinemark USA, Inc. would be required to make an offer to repurchase the 8.750% Secured Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 8.750% Secured Notes allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies a coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. Issuance of 4.50% Convertible Senior Notes On August 21, 2020, Cinemark Holdings, Inc. issued $460,000 4.50% convertible senior notes (the “4.50% Convertible Senior Notes”). The 4.50% Convertible Senior Notes will mature on August 15, 2025, unless earlier repurchased or converted in accordance with the indenture. Interest on the 4.50% Convertible Senior Notes will be payable on February 15 and August 15 of each year, beginning on February 15, 2021. Holders of the 4.50% Convertible Senior Notes may convert their 4.50% Convertible Senior Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2025 only under the following circumstances: ; (1) during the five business day period after any five consecutive trading day period, or the measurement period, in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on each such trading day; (2) if the Company distributes to all or substantially all stockholders (i) rights options or warrants entitling them to purchase shares at a discount to the recent average trading price of the Company’s common stock (including due to a stockholder rights plan) or (ii) the Company’s assets or securities or rights, options or warrants to purchase the same with a per share value exceeding 10% of the trading price of the Company’s stock, (3) upon the occurrence of specified corporate events as described further in the indenture, or (4) during any calendar quarter commencing after th e calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days during the period of 30 consecutive trading days ending on the last trad ing day of the immediately preceding calendar quarter is greater than or equal to 130 % of the conversion price (initially 14.35 per share), on each applicable trading day. Beginning May 15, 2025, holders may convert their notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date. Upon conversion of the notes, the Company will pay or deliver cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s co mmon stock, at the Company’s election. The conversion rate will initially be 69.6767 shares of the Company’s common stock per $1,000 principal amount of the 4.50% Convertible Senior Notes. The conversion rate will be subject to adjustment upon the occurrence of certain events. If a make-whole fundamental change as defined in the indenture governing the 4.50% Convertible Senior Notes occurs prior to the maturity date, the Company will, in certain circumstances, increase the conversion rate for a holder who elects to convert its 4.50% Convertible Senior Notes in connection with such make-whole fundamental change. The 4.50% Convertible Senior Notes will be effectively subordinated to any of the Company’s, or its subsidiaries’, existing and future secured debt to the extent of the value of the assets securing such indebtedness, including obligations under the Credit Agreement. The 4.50% Convertible Senior Notes will be structurally subordinated to all existing and future debt and other liabilities, including trade payables, including Cinemark USA’s 5.125% senior notes due 2022, 4.875% senior notes due 2023 and the 8.750% Secured Notes due 2025, or, collectively, Cinemark USA’s senior notes (but excluding all obligations under the Credit Agreement which are guaranteed by the Company). The 4.50% Convertible Senior Notes rank equally in right of payment with all of the Company’s existing and future unsubordinated debt, including all obligations under the Cinemark USA, Inc. Credit Agreement, which such Credit Agreement is guaranteed by the Company, and senior in right of payment to any future debt that is expressly subordinated in right of payment to the 4.50% Convertible Senior Notes. The 4.50% Convertible Notes are not guaranteed by any of Cinemark Holdings, Inc.’s subsidiaries. In accordance with accounting guidance on debt and equity financing, the Company bifurcated the gross proceeds from the issuance of 4.50% Convertible Senior Notes and recorded a portion as long-term debt and a portion in equity. The long-term debt value was based on the fair value of the debt, determined as the present value of principal and interest payments assuming a market interest rate for similar debt that excluded a conversion feature. The difference between the face value of the 4.50% Convertible Senior Notes and the fair value is referred to as the debt discount, and represents the amount allocated to equity. The debt discount is being amortized to interest expense at an effective interest rate of 10.00% over the contractual terms of the notes. Concurrently with the issuance of the 4.50% Convertible Senior Notes, the Company entered into privately negotiated convertible note hedge transactions (the “Hedge Transactions”) with one or more of the Initial Purchasers or their respective affiliates (the “Option Counterparties”). The Hedge Transactions cover the number of shares of the Company’s common stock that will initially underlie the aggregate amount of the 4.50% Convertible Senior Notes, subject to anti-dilution adjustments substantially similar to those applicable to the 4.50% Convertible Senior Notes. The Hedge Transactions are generally expected to reduce potential dilution to the Company’s common stock upon any conversion of the 4.50% Convertible Senior Notes and/or offset any cash payments the Company may be required to make in excess of the principal amount of converted 4.50% Convertible Senior Notes, as the case may be. Concurrently with entering into the Hedge Transactions, the Company also entered into separate privately negotiated warrant transactions with Option Counterparties whereby it sold to Option Counterparties warrants to purchase (subject to the net share settlement provisions set forth therein) up to the same number of shares of the Company’s common stock, subject to customary anti-dilution adjustments (the “Warrants”). The Warrants could separately have a dilutive effect to the extent that the market value per share of the Company’s common stock exceeds the strike price of the warrants on the applicable expiration dates unless, subject to the terms of the Warrants, the Company elects to cash settle the Warrants. The exercise price of the Warrants is initially $22.08 and is subject to certain adjustments under the terms of the warrants. The Company received $89,424 in cash proceeds from the sale of Warrants, which were used along with proceeds from the 4.50% Convertible Senior Notes, to pay approximately $142,094 to enter into the Hedge Transactions. The tax impact of the conversion option and Warrants amounted to $10,960 and was recorded in additional paid-in-capital. Together, the Hedge Transactions and the Warrants are intended to reduce the potential dilution from the conversion of the 4.50% Convertible Senior Notes. The Hedge Transactions and Warrants are recorded in equity and are not accounted for as derivatives, in accordance with applicable accounting guidance. Additional Borrowings of International Subsidiaries During May 2020, the Company’s subsidiary in Peru borrowed the USD equivalent of approximately $2,811 under a loan that bears interest at approximately 1%. Principal payments are due monthly beginning in July 2021 June 2023 unpaid interest is to be paid when principal payments are due. The C ompany is subject to certain customary negative covenants under the loan. During May, June and September 2020, the Company’s subsidiary in Colombia borrowed the USD equivalent of approximately $4,357 under three variable rate loans. Aggregate principal payments are due monthly beginning in December 2020 September 2025 Interest Rate Swap Agreements Effective March 31, 2020, the Company amended and extended its three existing interest rate swap agreements and entered into a fourth interest rate swap agreement, all of which are used to hedge a portion of the interest rate risk associated with the variable interest rates on the Company’s term loan debt and qualify for cash flow hedge accounting. Below is a summary of the Company’s interest rate swap agreements designated as cash flow hedges as of September 30, 2020: Estimated Fair Value at Notional September 30, Amount Effective Date Pay Rate Receive Rate Expiration Date 2020 (1) $ 137,500 December 31, 2018 2.12% 1-Month LIBOR December 31, 2024 $ 10,719 $ 175,000 December 31, 2018 2.12% 1-Month LIBOR December 31, 2024 13,647 $ 137,500 December 31, 2018 2.19% 1-Month LIBOR December 31, 2024 11,192 $ 150,000 March 31, 2020 0.57% 1-Month LIBOR March 31, 2022 926 Total $ 36,484 (1) Approximately $9,763 of the total is included in accounts payable and accrued expenses and $26,721 is included in other long-term liabilities on the condensed consolidated balance sheet as of September 30, 2020. Upon amending the interest rate swap agreements effective March 31,2020, the Company determined that the interest payments hedged with the agreements are still probable to occur, therefore the loss that accumulated on the swaps prior to the amendments of $29,359 is being amortized to interest expense through December 31, 2022, the original maturity dates of the swaps. Approximately $2,669 and $5,338 was recorded in amortization of accumulated losses for amended swaps in the condensed consolidated income statement for the three and nine months ended September 30, 2020, respectively. The fair values of the amended interest rate swaps and the new interest rate swap are recorded on the Company’s condensed consolidated balance sheet as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss. The changes in fair value are reclassified from accumulated other comprehensive loss into earnings in the same period that the hedged items affect earnings. The valuation technique used to determine fair value is the income approach. Under this approach, the Company uses projected future interest rates, which fall in Level 2 of the U.S. GAAP hierarchy as defined by FASB ASC Topic 820-10-35, as provided by counterparties to the interest rate swap agreements and the fixed rates that the Company is obligated to pay under the agreements. Fair Value of Long-Term Debt The Company estimates the fair value of its long-term debt using the market approach, which utilizes quoted market prices that fall under Level 2 of the U.S. GAAP fair value hierarchy as defined by ASC 820, Fair Value Measurement .

Equity

Equity	9 Months Ended
	Sep. 30, 2020
Equity [Abstract]
Equity	8. Equity Below is a summary of changes in stockholders’ equity attributable to Cinemark Holdings, Inc., noncontrolling interests and total equity for the three and nine months ended September 30, 2020 and 2019: Common Stock Treasury Stock Additional Paid-In-Capital Retained Earnings Accumulated Other Comprehensive Loss Total Cinemark Holdings, Inc. Stockholders’ Equity Noncontrolling Interests Total Equity Balance at January 1, 2020 $ 122 $ (81,567 ) $ 1,170,039 $ 687,332 $ (340,112 ) $ 1,435,814 $ 12,508 $ 1,448,322 Issuance of share based awards and share based awards compensation expense — — 4,111 — — 4,111 — 4,111 Stock withholdings related to share based awards that vested during the three months ended March 31, 2020 — (2,691 ) — — — (2,691 ) — (2,691 ) Dividends paid to stockholders, $0.36 per common share (1) — — — (42,311 ) — (42,311 ) — (42,311 ) Dividends paid to noncontrolling interests — — — — — — (392 ) (392 ) Dividends accrued on unvested restricted stock unit awards (1) — — — (256 ) — (256 ) — (256 ) Net income (loss) — — — (59,591 ) — (59,591 ) 169 (59,422 ) Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements — — — — (24,171 ) (24,171 ) — (24,171 ) Foreign currency translation adjustments — — — — (57,625 ) (57,625 ) — (57,625 ) Balance at March 31, 2020 122 (84,258 ) 1,174,150 585,174 (421,908 ) 1,253,280 12,285 1,265,565 Issuance of share based awards and share based awards compensation expense — — 4,321 — — 4,321 — 4,321 Stock withholdings related to share based awards that vested during the three months ended June 30, 2020 — (107 ) — — — (107 ) — (107 ) Net loss — — — (170,389 ) — (170,389 ) (427 ) (170,816 ) Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements — — — — 849 849 — 849 Amortization of accumulated losses for amended swap agreements — — — — 2,669 2,669 — 2,669 Foreign currency translation adjustments — — — — (3,702 ) (3,702 ) — (3,702 ) Balance at June 30, 2020 122 (84,365 ) 1,178,471 414,785 (422,092 ) 1,086,921 11,859 1,098,780 Issuance of share based awards and share based awards compensation expense 1 — 4,427 — 4,428 4,428 Stock withholdings related to share based awards that vested during the three months ended September 30, 2020 — (67 ) — — — (67 ) — (67 ) Net loss — — — (147,592 ) — (147,592 ) (444 ) (148,036 ) Issuance of convertible senior notes, net of allocated debt issue costs — — 97,359 — — 97,359 — 97,359 Tax impact of convertible notes issued — — 10,960 — — 10,960 — 10,960 Call options purchased — — (142,094 ) — — (142,094 ) — (142,094 ) Proceeds from issuance of warrants — — 89,424 — — 89,424 — 89,424 Unrealized gain to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements — — — — 6,528 6,528 — 6,528 Amortization of accumulated losses for amended swap agreements — — — — 2,669 2,669 — 2,669 Foreign currency translation adjustments — — — — (1,503 ) (1,503 ) — (1,503 ) Balance at September 30, 2020 $ 123 $ (84,432 ) $ 1,238,547 $ 267,193 $ (414,398 ) $ 1,007,033 $ 11,415 $ 1,018,448 Common Stock Treasury Stock Additional Paid-In-Capital Retained Earnings Accumulated Other Comprehensive Loss Total Cinemark Holdings, Inc. Stockholders’ Equity Noncontrolling Interests Total Equity Balance at January 1, 2019 $ 121 $ (79,259 ) $ 1,155,424 $ 686,459 $ (319,007 ) $ 1,443,738 $ 12,379 $ 1,456,117 Cumulative effect of change in accounting principle, net of taxes of $6,054 — — — 16,985 — 16,985 — 16,985 Issuance of share based awards and share based awards compensation expense — — 2,970 — 2,970 — 2,970 Stock withholdings related to share based awards that vested during the three months ended March 31, 2019 — (1,947 ) — — — (1,947 ) — (1,947 ) Dividends paid to stockholders, $0.34 per common share (1) — — — (39,797 ) — (39,797 ) — (39,797 ) Dividends paid to noncontrolling interests — — — — — — (1,000 ) (1,000 ) Dividends accrued on unvested restricted stock unit awards (1) — — — (108 ) — (108 ) — (108 ) Net income — — — 32,728 — 32,728 465 33,193 Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements — — — — (3,311 ) (3,311 ) — (3,311 ) Other comprehensive loss in equity method investees — — — — (71 ) (71 ) — (71 ) Foreign currency translation adjustments — — — — 755 755 — 755 Balance at March 31, 2019 121 (81,206 ) 1,158,394 696,267 (321,634 ) 1,451,942 11,844 1,463,786 Issuance of share based awards and share based awards compensation expense 1 — 3,676 — — 3,677 — 3,677 Stock withholdings related to share based awards that vested during the three months ended June 30, 2019 — (300 ) — — — (300 ) — (300 ) Dividends paid to stockholders, $0.34 per common share (1) — — — (39,823 ) — (39,823 ) — (39,823 ) Dividends paid to noncontrolling interests — — — — — — (294 ) (294 ) Dividends accrued on unvested restricted stock unit awards (1) — — — (189 ) — (189 ) — (189 ) Net income — — — 100,971 — 100,971 890 101,861 Other comprehensive loss in equity method investees — — — — (22 ) (22 ) — (22 ) Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements — — — — (5,902 ) (5,902 ) — (5,902 ) Foreign currency translation adjustments — — — — 4,925 4,925 — 4,925 Balance at June 30, 2019 $ 122 $ (81,506 ) $ 1,162,070 $ 757,226 $ (322,633 ) $ 1,515,279 $ 12,440 $ 1,527,719 Issuance of share based awards and share based awards compensation expense — — 3,840 — — 3,840 — 3,840 Dividends paid to stockholders, $0.34 per common share (1) — — — (39,832 ) — (39,832 ) — (39,832 ) Dividends paid to noncontrolling interests — — — — — — (294 ) (294 ) Dividends accrued on unvested restricted stock unit awards (1) — — — (189 ) — (189 ) — (189 ) Net income — — — 31,353 — 31,353 602 31,955 Other comprehensive loss in equity method investees — — — — (49 ) (49 ) — (49 ) Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements — — — — (1,291 ) (1,291 ) — (1,291 ) Foreign currency translation adjustments — — — — (25,408 ) (25,408 ) — (25,408 ) Balance at September 30, 2019 $ 122 $ (81,506 ) $ 1,165,910 $ 748,558 $ (349,381 ) $ 1,483,703 $ 12,748 $ 1,496,451 (1 ) Below is a summary of dividends paid to stockholders as well as dividends accrued on unvested restricted stock units during the nine months ended September 30, 2020 and 2019: Amount per Share Declaration Date Record Date Payable Date of Common Stock Total 2/21/2020 3/6/2020 3/20/2020 $ 0.36 $ 42,567 Nine Months Ended September 30, 2020 $ 0.36 $ 42,567 2/22/2019 3/8/2019 3/22/2019 $ 0.34 $ 39,905 5/23/2019 6/8/2019 6/24/2019 0.34 40,012 8/15/2019 9/4/2019 9/18/2019 0.34 40,021 Nine Months Ended September 30, 2019 $ 1.02 $ 119,938

National CineMedia

National CineMedia	9 Months Ended
	Sep. 30, 2020
NCM
National CineMedia	9. National CineMedia Below is a summary of activity with NCM included in the Company’s condensed consolidated financial statements: Investment in NCM NCM Screen Advertising Advances Distributions from NCM Equity in Loss Other Revenue Interest Expense - NCM Cash Received Balance as of January 1, 2020 $ 265,792 $ (348,354 ) Receipt of common units due to annual common unit adjustment ("CUA") 3,620 (3,620 ) $ — $ — $ — $ — $ — Screen rental revenues earned under ESA (1) — — — — (4,209 ) — 4,209 Interest accrued related to significant financing component — (17,726 ) — — — 17,726 — Receipt of excess cash distributions (14,168 ) — (6,975 ) — — — 21,143 Equity in loss (4,810 ) — — 4,810 — — — Amortization of screen advertising advances — 23,463 — — (23,463 ) — — Balance as of and for the nine months ended September 30, 2020 $ 250,434 $ (346,237 ) $ (6,975 ) $ 4,810 $ (27,672 ) $ 17,726 $ 25,352 (1) Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire of approximately $2,243. Investment in National CineMedia NCM operates a digital in-theatre network in the U.S. for providing cinema advertising. The Company entered into an Exhibitor Services Agreement with NCM (“ESA”), pursuant to which NCM primarily provides advertising to our theatres. recognizes cash distributions it receives from NCM on its Tranche 1 Investment as a component of earnings as Distributions from NCM. Common Unit Adjustments In addition to the consideration received upon the NCMI IPO and ESA modification in 2007, the Company also periodically receives consideration in the form of common units from NCM. Pursuant to a Common Unit Adjustment Agreement dated as of February 13, 2007 between NCMI and the Company, annual adjustments to the common membership units are made primarily based on increases or decreases in the number of theatre screens operated and theatre attendance generated. As discussed in Note 7 to the Company’s financial statements as included in its 2019 Annual Report on Form 10-K, the common units received (collectively referred to as the Company’s “Tranche 2 Investment”) are recorded at estimated fair value as an increase in the Company’s investment in NCM with an offset to NCM screen advertising advances. The Company’s Tranche 2 Investment is accounted for following the equity method, with undistributed equity earnings related to its Tranche 2 Investment included as a component of earnings in equity in income of affiliates and distributions received related to its Tranche 2 Investment are recorded as a reduction of investment basis. During March 2020, NCM performed its annual common unit adjustment calculation under the Common Unit Adjustment Agreement. As a result of the calculation, the Company received an additional 1,112,368 common units of NCM, each of which is convertible into one share of NCMI common stock. The Company recorded the additional common units received at estimated fair value with a corresponding adjustment to NCM screen advertising advances of approximately $3,620. The fair value of the common units received was estimated based on the market price of NCMI common stock at the time the common units were determined, adjusted for volatility associated with the estimated time period it would take to convert the common units and register the respective shares. As of September 30, 2020, the Company owned a total of 40,850,068 common units of NCM, representing an ownership interest of approximately 25%. Each of the Company’s common units in NCM is convertible into one share of NCM, Inc. common stock. As of September 30, 2020, the estimated fair value of the Company’s investment in NCM was approximately $111,112 based on NCM, Inc.’s stock price as of September 30, 2020 of $2.72 per share (Level 1 input as defined in FASB ASC Topic 820), which was below the Company’s carrying value of $250,434. The market value of NCM, Inc.’s stock price may vary due to the performance of the business, industry trends, general and economic conditions and other factors, including those resulting from the impact of COVID-19 (see Note 2). The Company does not believe that the decline in NCM, Inc.’s stock price is other than temporary Exhibitor Services Agreement As discussed above, the Company’s domestic theatres are part of the in-theatre digital network operated by NCM under the ESA. NCM provides advertising to the Company’s theatres through its branded “ Noovie Revenue from Contracts with Customers. The recognition of revenue related to the NCM screen advertising advances will be recorded on a straight-line basis through February 2041. Twelve Months Ended September 30, Remaining Maturity 2021 2022 2023 2024 2025 Thereafter Total NCM screen advertising advances $ 8,131 $ 8,693 $ 9,295 $ 9,940 $ 10,630 $ 299,548 $ 346,237 Significant Financing Component Prior to the September 17, 2019 amendment of the ESA, the Company applied a significant financing component, as required by ASC Topic 606, due to the significant length of time between receiving the NCM screen advertising advances (the $174,000 received at the NCMI IPO and the periodic common unit adjustments) and completion of the performance obligation. Effective September 17, 2019, upon the Company’s evaluation and determination that ASC Topic 842 applies to the amended ESA, the Company determined it acceptable to apply the significant financing component guidance from ASC Topic 606 by analogy as the economic substance of the agreement represents a financing arrangement. As a result of the significant financing component, the Company recognized incremental screen rental revenue and an offsetting interest expense of $23,463 and $17,726, respectively, during the nine months ended September 30, 2020. The interest expense was calculated using the Company’s incremental borrowing rates at the time when the cash was received from the NCMI IPO and each tranche of common units was received from NCM, which ranged from 4.4% to 8.3%. NCM Financial Information Below is summary financial information for NCM for the periods indicated: Three Three Months ended Nine Months Ended Nine Months Ended September 24, 2020 September 26, 2019 September 24, 2020 September 26, 2019 Gross revenues $ 6,000 $ 110,513 $ 74,700 $ 297,613 Operating income (loss) $ (20,073 ) $ 39,349 $ (38,973 ) $ 87,949 Net income (loss) $ (34,950 ) $ 25,307 $ (81,350 ) $ 45,907 As of As of September 24, 2020 December 26, 2019 Current assets $ 170,749 $ 185,400 Noncurrent assets $ 693,018 $ 706,600 Current liabilities $ 47,153 $ 125,500 Noncurrent liabilities $ 1,073,742 $ 947,800 Members deficit $ (257,128 ) $ (181,300 )

Other Investments

Other Investments	9 Months Ended
	Sep. 30, 2020
Financial Support For Nonconsolidated Legal Entity [Abstract]
Other Investments	10. Other Investments Below is a summary of activity for each of the Company’s other investments for the nine months ended September 30, 2020: DCIP AC JV, LLC DCDC FE Concepts Other Total Balance at January 1, 2020 $ 124,696 $ 5,022 $ 3,169 $ 19,519 $ 2,879 $ 155,285 Cash distributions received (10,383 ) — (878 ) — — (11,261 ) Equity loss (20,083 ) (618 ) (1,197 ) (1,003 ) — (22,901 ) Other 50 — — — (2,584 ) (2,534 ) Balance at September 30, 2020 $ 94,280 $ 4,404 $ 1,094 $ 18,516 $ 295 $ 118,589 Digital Cinema Implementation Partners LLC (“DCIP”) On February 12, 2007, the Company, AMC and Regal (the “Exhibitors”) entered into a joint venture known as DCIP to facilitate the implementation of digital cinema in the Company’s theatres and to establish agreements with major motion picture studios for the financing of digital cinema. On March 10, 2010, DCIP and its subsidiaries completed an initial financing transaction to enable the purchase, deployment and leasing of digital projection systems to the Exhibitors under equipment lease and installation agreements. On March 31, 2011, DCIP obtained incremental financing necessary to complete the deployment of digital projection systems. DCIP also entered into long-term Digital Cinema Deployment Agreements (“DCDAs”) with six major motion picture studios pursuant to which Kasima LLC, one of DCIP’s subsidiaries, receives a virtual print fee ("VPF") each time the studio books a film or certain other content on the leased digital projection systems. Other content distributors entered into similar DCDAs that provide for the payment of VPFs for bookings of the distributor's content on a leased digital projection system. The DCDAs end on the earlier to occur of (i) the tenth anniversary of the "mean deployment date" for all digital projection systems scheduled to be deployed over a period of up to five years , or (ii) the date DCIP achieves "cost recoupment", each as defined in the DCDAs. Cost recoupment occurs when revenues attributable to the digital projection systems exceed the financing, deployment, administration and other costs associated with the purchase of the digital pr ojection systems. DCIP expects cost recoupment to occur during 2021. The timing of cost recoupment is dependent on VPF payments from studios. Pursuant to the operating agreement between the Exhibitors and DCIP, DCIP began to distribute excess cash to the Exhibitors upon the payoff of its outstanding debt, which occurred during the year ended December 31, 2019 . As of September 30, 2020, the Company had a 33% voting interest in DCIP and a 24.3% economic interest in DCIP. The Company accounts for its investment in DCIP and its subsidiaries under the equity method of accounting. Below is summary financial information for DCIP for the periods indicated: Three Months Ended Nine Months Ended September 30, 2020 September 30, 2019 September 30, 2020 September 30, 2019 Gross revenues $ 1,084 $ 40,200 $ 20,809 $ 125,869 Operating income (loss) $ (29,878 ) $ 22,617 $ (72,422 ) $ 73,396 Net income (loss) $ (30,554 ) $ 22,362 $ (79,660 ) $ 69,323 As of September 30, 2020 December 31, 2019 Current assets $ 28,299 $ 51,382 Noncurrent assets $ 461,276 $ 581,547 Current liabilities $ 58,375 $ 70,515 Noncurrent liabilities $ 710 $ 190 Members' equity $ 430,490 $ 562,224 As of September 30, 2020, the Company had 3,812 digital projection systems being leased under the master equipment lease agreement with Kasima LLC, which is an indirect subsidiary of DCIP and a related party to the Company. The Company had the following transactions with DCIP, reflected in utilities and other costs on the condensed consolidated statements of income, during the three and nine months ended September 30, 2020 and 2019: Three Months Ended Nine Months Ended September 30, 2020 September 30, 2019 September 30, 2020 September 30, 2019 Equipment lease payments (1) $ 346 $ 1,105 $ 1,384 $ 3,357 Warranty reimbursements from DCIP $ — $ (2,953 ) $ (3,123 ) $ (8,842 ) Management service fees $ — $ 128 $ 84 $ 438 (1) The Company negotiated an abatement of lease payments during the temporary closure of its theatres as a result of the COVID-19 pandemic. The Company did not remeasure its lease liabilities and lease right-of-use assets as a result of these negotiations in accordance with FASB guidance. See further discussion at Note 4. AC JV, LLC During December 2013, the Company, Regal, AMC (the “AC Founding Members”) and NCM entered into a series of agreements that resulted in the formation of AC JV, LLC (“AC”), a joint venture that owns “Fathom Events” formerly operated by NCM. The Fathom Events business focuses on the marketing and distribution of live and pre-recorded entertainment programming to various theatre operators, including concerts, opera and symphony, DVD product releases and marketing events, theatrical premieres, Broadway plays, live sporting events and other special events. The Company paid event fees to AC of $2,258 and $10,332 for the nine months ended September 30, 2020 and 2019, respectively, which are included in film rentals and advertising costs on the condensed consolidated statements of income. The Company accounts for its investment in AC under the equity method of accounting. Digital Cinema Distribution Coalition Digital Cinema Distribution Coalition (“DCDC”) is a joint venture among the Company, Universal, Warner Bros., AMC and Regal. DCDC operates a satellite distribution network that distributes all digital content to U.S. theatres via satellite. The Company ha s an approximate 14.6 % ownership in DCDC. The Company paid approximately $ 208 and $ 703 to DCDC during the nine months ended September 30, 2020 and 2019 , respectively, related to content delivery services provided by DCDC. These fees are includ ed in film rentals and advertising costs on the condensed consolidated statements of income . The Company accounts for its investment in DCDC under the equity method of accounting. FE Concepts, LLC During April 2018, the Company, through its wholly-owned indirect subsidiary CNMK Texas Properties, LLC (“CNMK”), formed a joint venture, FE Concepts, LLC (“FE Concepts”) with AWSR Investments, LLC (“AWSR”), an entity owned by Lee Roy Mitchell and Tandy Mitchell. FE Concepts operates a family entertainment center that offers bowling, gaming, movies and other amenities that opened during December 2019. The Company and AWSR each invested approximately $20,000 and each have a 50% voting interest in FE Concepts. The Company accounts for its investment in FE Concepts under the equity method of accounting. The Company has a theatre services agreement with FE Concepts under which it provides film booking and equipment monitoring services. The Company recorded $3 and $19 of theatre services revenue under the agreement during the three and nine months ended September 30, 2020, respectively. Additional Considerations Each of the investments above have been adversely impacted by the COVID-19 pandemic (see Note 2) due to the temporary closure of theatres across the U.S. The Company does not believe that any resulting decline in value of the underlying investments is other than temporary as the Company and other industry participants, who also have equity ownership interests in certain of the above investments, have reopened some theatres and will continue to reopen theatres as local government restrictions allow. The Company expects the industry to recover gradually over time.

Treasury Stock and Share Based

Treasury Stock and Share Based Awards	9 Months Ended
	Sep. 30, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Treasury Stock and Share Based Awards	11. Treasury Stock and Share Based Awards Treasury Stock — Treasury stock represents shares of common stock repurchased or withheld by the Company and not yet retired. The Company has applied the cost method in recording its treasury shares. Below is a summary of the Company’s treasury stock activity for the nine months ended September 30, 2020: Number of Treasury Shares Cost Balance at January 1, 2020 4,711,859 $ 81,567 Restricted stock withholdings (1) 100,548 2,865 Restricted stock forfeitures 56,133 — Balance at September 30, 2020 4,868,540 $ 84,432 (1) The Company withheld restricted shares as a result of the election by certain employees to satisfy their tax liabilities upon vesting in restricted stock and restricted stock units. The Company determined the number of shares to be withheld based upon market values ranging from $8.03 to $32.12 per share. As of September 30, 2020, the Company had no plans to retire any shares of treasury stock. Restricted Stock – During the nine months ended September 30, 2020, the Company granted 1,045,885 shares of restricted stock to its directors and employees of the Company. The fair value of the restricted stock granted was determined based on the market value of the Company’s common stock on the dates of grant, which ranged from $8.39 to $32.12 per share. The Company assumed forfeiture rates for the restricted stock awards that ranged from 0% to 10%. The restricted stock awards vest over periods ranging from one to four years. The recipients of restricted stock are entitled to receive non-forfeitable dividends and to vote their respective shares, however, the sale and transfer of the restricted shares is prohibited during the restriction period. Below is a summary of restricted stock activity for the nine months ended September 30, 2020: Shares of Weighted Average Restricted Grant Date Stock Fair Value Outstanding at January 1, 2020 783,823 $ 37.53 Granted 1,045,885 $ 18.35 Vested (326,281 ) $ 35.63 Forfeited (56,133 ) $ 33.63 Outstanding at September 30, 2020 1,447,294 $ 24.25 Unvested restricted stock at September 30, 2020 1,447,294 $ 24.25 Nine Months Ended September 30, 2020 2019 Compensation expense recognized during the period $ 8,235 $ 7,456 Fair value of restricted shares that vested during the period $ 8,944 $ 7,630 Income tax benefit recognized upon vesting of restricted stock awards $ 2,678 $ 1,473 As of September 30, 2020, the estimated remaining unrecognized compensation expense related to unvested restricted stock awards was $22,858 and the weighted average period over which this remaining compensation expense will be recognized is approximately two years. Impact of 2020 Restructuring Plan - As part of the Company’s employee-related restructuring actions discussed in Note 2, the vesting period for certain share based awards will be accelerated on a pro-rata basis based upon the grant dates and each employee’s separation date. The Company considers the accelerated vest of these awards to be a modification under ASC Topic 718 . Based on the terms of the severance agreements, the Company estimated the number of awards expected to vest at each employee’s expected separation date and revalued such awards based on the modification date, or the date on which employees were notified of the 2020 Restructuring Plan. The modification date fair value per share was $15.95. The Company recorded incremental compensation expense of approximately $521 related to these modifications, which is reflected in restructuring costs on the Company’s condensed consolidated income statement. Restricted Stock Units – During the nine months ended September 30, 2020, the Company granted restricted stock units representing 436,681 hypothetical shares of common stock to employees. The restricted stock units vest based on a combination of financial performance factors and continued service. The financial performance factors are based on an implied equity value concept that determines an internal rate of return (“IRR”) during the two fiscal year periods ending December 31, 2021 based on a formula utilizing a multiple of Adjusted EBITDA subject to certain adjustments as specified by the Compensation Committee prior to the grant date. The financial performance factors for the restricted stock units have a threshold, target and maximum level of payment opportunity and vest on a prorata basis according to the IRR achieved by the Company during the performance period. If the IRR for the two-year one-third two-thirds Below is a table summarizing the potential number of shares that could vest under restricted stock unit awards granted during the nine months ended September 30, 2020 Number of Shares Value at Vesting Grant at IRR of at least 6% 190,707 $ 6,125 at IRR of at least 8% 286,060 $ 9,188 at IRR of at least 14% 436,681 $ 14,026 Due to the fact that the IRR for the two-year performance period could not be determined at the time of the 2020 grant, the Company estimated that the most likely outcome is the achievement of the target IRR level. The fair value of the restricted stock unit awards was determined based on the closing price of the Company’s common stock on the date of grant, which was $32.12 per share. The Company assumed a forfeiture rate of 5% for the restricted stock unit awards. If during the service period, additional information becomes available to lead the Company to believe a different IRR level will be achieved for the two-year performance period, the Company will reassess the number of units that are expected to vest for the grant and adjust its compensation expense accordingly on a prospective basis over the remaining service period. Nine Months Ended September 30, 2020 2019 Number of restricted stock unit awards that vested during the period 120,293 88,074 Fair value of restricted stock unit awards that vested during the period $ 3,669 $ 3,550 Accumulated dividends paid upon vesting of restricted stock unit awards $ 576 $ 375 Compensation expense recognized during the period $ 4,624 $ 3,030 Income tax benefit recognized upon vesting of restricted stock unit awards $ 215 $ 175 As of September 30, 2020, the estimated remaining unrecognized compensation expense related to the outstanding restricted stock unit awards was $13,559. The weighted average period over which this remaining compensation expense will be recognized is approximately two years. As of September 30, 2020, the Company had restricted stock units outstanding that represented a total of 978,591 hypothetical shares of common stock, net of forfeitures, assuming an IRR of 9.3% was achieved for the 2017 grants, an IRR of 8.6% was achieved for the 2018 grants and the maximum IRR level is achieved for all other grants outstanding.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	9 Months Ended
	Sep. 30, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	12. Goodwill and Other Intangible Assets A summary of the Company’s goodwill is as follows: U.S. Operating Segment International Operating Segment Total Balance at January 1, 2020 (1) $ 1,182,853 $ 100,518 $ 1,283,371 Impairment — (16,128 ) (16,128 ) Foreign currency translation adjustments — (17,816 ) (17,816 ) Balance at September 30, 2020 $ 1,182,853 $ 66,574 $ 1,249,427 (1) Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment. (2) See Note 13 for discussion of impairment evaluations performed during the nine months ended September 30, 2020. A summary of the Company’s intangible assets is as follows: Balance at January 1, 2020 Amortization Other (1) Balance at September 30, 2020 Intangible assets with finite lives: Gross carrying amount $ 85,007 $ — $ (2,018 ) $ 82,989 Accumulated amortization (63,924 ) (3,569 ) — (67,493 ) Total net intangible assets with finite lives $ 21,083 $ (3,569 ) $ (2,018 ) $ 15,496 Intangible assets with indefinite lives: Tradename and other 300,686 — (613 ) 300,073 Total intangible assets — net $ 321,769 $ (3,569 ) $ (2,631 ) $ 315,569 (1) Amount primarily represents foreign currency translation adjustments. The estimated aggregate future amortization expense for intangible assets is as follows: For the three months ended December 31, 2020 $ 1,373 For the twelve months ended December 31, 2021 2,765 For the twelve months ended December 31, 2022 2,612 For the twelve months ended December 31, 2023 2,514 For the twelve months ended December 31, 2024 2,514 Thereafter 3,718 Total $ 15,496

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets	9 Months Ended
	Sep. 30, 2020
Impairment Or Disposal Of Tangible Assets Disclosure [Abstract]
Impairment of Long-Lived Assets	13. Impairment of Long-Lived Assets Due to the temporary closure of the Company’s theatres effective March 18, 2020 as a result of the COVID-19 pandemic (see Note 2), the Company performed long-lived asset impairment evaluations during each quarter during the nine months ended September 30, 2020. The following table is a summary of the evaluations performed by asset classification. Impairment Asset Valuation Valuation Test Category Approach Multiple First Quarter Quantitative Goodwill Market (1) 8 times Tradename Intangible Assets Income N/A Other Long-lived Assets Market 6 times Second Quarter Qualitative Goodwill N/A N/A Tradename Intangible Assets N/A N/A Other Long-lived Assets N/A N/A Third Quarter Quantitative Goodwill Market (1) 2.9 to 7 times Tradename Intangible Assets Income N/A Other Long-lived Assets Market 3.2 to 6 times (1) The Company also used the income approach to test goodwill for impairment for the respective period. Goodwill – The Company evaluates goodwill for impairment as follows: • Quantitative approach The Company evaluates goodwill for impairment at the reporting unit level and has allocated goodwill to the reporting unit based on an estimate of its relative fair value. Management considers the reporting unit to be each of its twenty regions in the U.S. and seven countries internationally with Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala considered one reporting unit (the Company does not have goodwill recorded for all of its international locations). Under its quantitative goodwill impairment analysis, the Company estimates the fair value of each reporting unit and compares it with its carrying value. Fair value is determined using the market approach, which is the most common valuation approach for the Company’s industry an d based on a multiple of cash flows for each reporting unit. The Company also performed its quantitative goodwill impairment analysis using the income approach to further validate the results of the assessment under the market approach. Significant judgm ent, including management’s estimates of the impact of temporary theatre closures and other considerations as a result of COVID-19, is involved in estimating future cash flows and fair values. The Company’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on projected operating performance of each reporting unit, relevant market transactions and industry trading multiples. • Qualitative approach The Company’s qualitative assessment of goodwill for each reporting unit considers economic and market conditions, industry trading multiples and the impact of recent developments and events on the estimated fair values as determined during its most recent quantitative assessment Tradename Intangible assets – The Company evaluates tradename intangible assets for impairment as follows: • Quantitative approach The Company compares the carrying values of tradename assets to their estimated fair values. Fair values were estimated by applying an estimated market royalty rate that could be charged for the use of the tradenames to forecasted future revenues, with an adjustment for the present value of such royalties. Significant judgment, including management’s estimate of market royalty rates and long-term revenue forecasts, is involved in estimating the tradename fair values. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, were based on projected revenue performance and expected industry trends, considering the temporary closure of its theatres and other considerations as a result of COVID-19. • Qualitative approach The Company’s qualitative assessment considers industry and market conditions and recent developments that may impact the revenues forecasts and other estimates used in its most recent quantitative assessment. Other Long-lived Assets – The Company evaluates other long-lived assets for impairment as follows: • Quantitative approach The Company performs a quantitative evaluation at the theatre level using estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. Significant judgment, including management’s estimate of the impact of temporary theatre closures and other considerations as a result of COVID-19, was involved in estimating cash flows and fair value. Fair value is determined based on a multiple of cash flows. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy, as defined by FASB ASC Topic 820-10-35, are based on projected operating performance, market transactions and industry trading multiples. • Qualitative approach The Company’s qualitative assessment considers relevant market transactions, industry trading multiples and recent developments that would impact its estimates of future cash flows. The following table is a summary of the impairment recorded as a result of the evaluations discussed above during the three and nine months ended September 30, 2020: Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 U.S. Segment Theatre properties $ 2,075 $ 24,502 $ 5,718 $ 26,754 Theatre operating lease right-of-use assets 1,123 2,157 7,075 10,204 Cost method investment 2,500 — 2,500 — U.S. total 5,698 26,659 15,293 36,958 International segment Theatre properties 938 645 5,422 6,796 Theatre operating lease right-of-use assets 1,654 — 4,194 1,628 Goodwill 16,128 — 16,128 — Intangible assets 177 — 177 — International total 18,897 645 25,921 8,424 Total Impairment $ 24,595 $ 27,304 $ 41,214 $ 45,382

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurements	14. Fair Value Measurements The Company determines fair value measurements in accordance with ASC Topic 820, which establishes a fair value hierarchy under which an asset or liability is categorized based on the lowest level of input significant to its fair value measurement. The levels of input defined by ASC Topic 820 are as follows: Level 1 – quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date; Level 2 – other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3 – unobservable and should be used to measure fair value to the extent that observable inputs are not available. Below is a summary of liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of September 30, 2020 and December 31, 2019: Carrying Fair Value Hierarchy Description As of, Value Level 1 Level 2 Level 3 Interest rate swap liabilities (1) September 30, 2020 $ 36,484 $ — $ 36,484 $ — Interest rate swap liabilities (1) December 31, 2019 $ 15,995 $ — $ 15,995 $ — (1) See further discussion of interest rate swaps at Note 7. The Company uses the market approach for fair value measurements on a nonrecurring basis in the impairment evaluations of its goodwill, intangible assets and long-lived assets (see Note 12 and Note 13). See additional explanation of fair value measurement techniques used for long-lived assets, goodwill and intangible assets in “Critical Accounting Policies” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, filed February 21, 2020. There were no changes in valuation techniques. The Company elected to perform its goodwill impairment evaluation using both the market approach and the income approach for the nine months ended September 30, 2020. There were no transfers in to or out of Level 1, Level 2 or Level 3 during the nine months ended September 30, 2020.

Foreign Currency Translation

Foreign Currency Translation	9 Months Ended
	Sep. 30, 2020
Foreign Currency [Abstract]
Foreign Currency Translation	15. Foreign Currency Translation The accumulated other comprehensive loss account in stockholders’ equity of $414,398 and $340,112 as of September 30, 2020 and December 31, 2019, respectively, primarily includes cumulative foreign currency net losses of $390,881 and $328,053, respectively, from translating the financial statements of the Company’s international subsidiaries and the cumulative changes in fair value of the Company’s interest rate swap agreements that are designated as hedges. As of September 30, 2020, all foreign countries where the Company has operations, other than Argentina, are non-highly inflationary, and the local currency is the same as the functional currency in all of the locations. Thus, any fluctuation in the currency results in a cumulative foreign currency translation adjustment recorded to accumulated other comprehensive loss. The Company deemed Argentina to be highly inflationary beginning July 1, 2018. A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year Foreign Currency Matters Below is a summary of the impact of translating the September 30, 2020 and 2019 financial statements of the Company’s international subsidiaries: Other Comprehensive Income (Loss) for Exchange Rate as of Nine Months Ended Country September 30, 2020 December 31, 2019 September 30, 2020 September 30, 2019 Brazil 5.63 4.02 $ (51,453 ) $ (14,492 ) Chile 785.93 736.86 (5,046 ) (4,017 ) Colombia 3,878.95 3,277.14 (2,584 ) (1,507 ) Peru 3.62 3.37 (3,187 ) (203 ) All other (560 ) 491 $ (62,830 ) $ (19,728 ) (1) Beginning July 1, 2018, Argentina was deemed highly inflationary. A gain of $1,053 and a loss of $3,356 for the nine months ended September 30, 2020 and 2019, respectively, is reflected as foreign currency exchange gain (loss) on the Company’s condensed consolidated statement of income as a result of translating Argentina financial results to U.S. dollars.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	9 Months Ended
	Sep. 30, 2020
Supplemental Cash Flow Elements [Abstract]
Supplemental Cash Flow Information	16. Supplemental Cash Flow Information The following is provided as supplemental information to the condensed consolidated statements of cash flows: Nine Months Ended September 30, 2020 2019 Cash paid for interest $ 53,364 $ 56,326 Cash paid (refunds received) for income taxes, net $ (108,776 ) $ 69,498 Noncash investing and financing activities: Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (1) $ (7,933 ) $ (13,642 ) Interest expense - NCM (see Note 9) $ (17,726 ) $ (14,180 ) Investment in NCM – receipt of common units (see Note 9) $ 3,620 $ 1,552 Dividends accrued on unvested restricted stock unit awards $ (257 ) $ (486 ) (1) Additions to theatre properties and equipment included in accounts payable as of September 30, 2020 and December 31, 2019 were $7,058 and $14,991, respectively.

Segments

Segments	9 Months Ended
	Sep. 30, 2020
Segment Reporting [Abstract]
Segments	17. Segments The Company manages its international market and its U.S. market as separate reportable operating segments, with the international segment consisting of operations in Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. Each segment’s revenue is derived from admissions and concession sales and other ancillary revenues. The Company uses Adjusted EBITDA, as shown in the reconciliation table below, as the primary measure of segment profit and loss to evaluate performance and allocate its resources. The Company does not report total assets by segment because that information is not used to evaluate the performance of or allocate resources between segments. Below is a breakdown of selected financial information by reportable operating segment: Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Revenues U.S. $ 34,639 $ 636,628 $ 472,096 $ 1,941,545 International 1,069 188,772 118,061 563,509 Eliminations (230 ) (3,583 ) (2,089 ) (10,758 ) Total revenues $ 35,478 $ 821,817 $ 588,068 $ 2,494,296 Adjusted EBITDA U.S. $ (105,767 ) $ 132,347 $ (145,947 ) $ 453,404 International (22,232 ) 37,411 (33,459 ) 113,346 Total Adjusted EBITDA $ (127,999 ) $ 169,758 $ (179,406 ) $ 566,750 Capital expenditures U.S. $ 17,903 $ 50,679 $ 54,604 $ 148,609 International 2,756 20,664 13,014 37,903 Total capital expenditures $ 20,659 $ 71,343 $ 67,618 $ 186,512 The following table sets forth a reconciliation of net income (loss) to Adjusted EBITDA: Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Net income (loss) $ (148,036 ) $ 31,955 $ (378,274 ) $ 167,009 Add (deduct): Income taxes (121,145 ) 14,053 (222,398 ) 64,152 Interest expense (1) 36,577 24,967 92,284 75,037 Other (income) expense, net (2) 22,881 (9,970 ) 47,385 (25,079 ) Cash distributions from DCIP (3) — 2,694 10,383 7,912 Cash distributions from other equity investees (4) 2,146 5,804 15,047 20,251 Depreciation and amortization 62,543 67,760 191,380 196,795 Impairment of long-lived assets 24,595 27,304 41,214 45,382 Restructuring costs 524 — 20,062 — (Gain) loss on disposal of assets and other (13,327 ) 2,453 (10,997 ) 8,057 Non-cash rent expense 816 (1,102 ) 1,649 (3,252 ) Share based awards compensation expense 4,427 3,840 12,859 10,486 Adjusted EBITDA $ (127,999 ) $ 169,758 $ (179,406 ) $ 566,750 (1) Includes amortization of debt issue costs and amortization of accumulated losses for amended swap agreements. (2) Includes interest income, foreign currency exchange gain (loss), equity in income of affiliates and interest expense - NCM and excludes distributions from NCM. (3) See discussion of cash distributions from DCIP, which were recorded as a reduction of the Company’s investment in DCIP, at Note 10. These distributions are reported entirely within the U.S. operating segment. (4) Includes cash distributions received from equity investees, other than those from DCIP noted above, that were recorded as a reduction of the respective investment balances (see Notes 9 and 10). These distributions are reported entirely within the U.S. operating segment. Financial Information About Geographic Areas Below is a breakdown of selected financial information by geographic area: Three Months Ended Nine Months Ended September 30, September 30, Revenues 2020 2019 2020 2019 U.S. $ 34,639 $ 636,628 $ 472,096 $ 1,941,545 Brazil 513 79,776 53,829 240,263 Other international countries 556 108,996 64,232 323,246 Eliminations (230 ) (3,583 ) (2,089 ) (10,758 ) Total $ 35,478 $ 821,817 $ 588,068 $ 2,494,296 As of As of Theatre Properties and Equipment-net September 30, 2020 December 31, 2019 U.S. $ 1,324,924 $ 1,436,275 Brazil 71,338 118,367 Other international countries 149,561 180,605 Total $ 1,545,823 $ 1,735,247

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2020
Related Party Transactions [Abstract]
Related Party Transactions	18. Related Party Transactions The Company manages theatres for Laredo Theatre, Ltd. (“Laredo”). The Company is the sole general partner and owns 75% of the limited partnership interests of Laredo. Lone Star Theatres, Inc. owns the remaining 25% of the limited partnership interests in Laredo and is 100% owned by Mr. David Roberts, Lee Roy Mitchell’s son-in-law. Lee Roy Mitchell is the Company’s Chairman of the Board of Directors and directly and indirectly owns approximately 8% of the Company’s common stock. Under the agreement, management fees are paid by Laredo to the Company at a rate of 5% of annual theatre revenues up to $50,000 and 3% of annual theatre revenues in excess of $50,000. The Company recorded $123 and $539 of management fee revenues during the nine months ended September 30, 2020 and 2019, respectively. All such amounts are included in the Company’s condensed consolidated financial statements with the intercompany amounts eliminated in consolidation. The Company has an Aircraft Time Sharing Agreement with Copper Beech Capital, LLC (“Copper Beech”) to use, on occasion, a private aircraft owned by Copper Beech. Copper Beech is owned by Mr. Mitchell and his wife, Tandy Mitchell. The private aircraft is used by Mr. Mitchell and other executives who accompany Mr. Mitchell to business meetings for the Company. The Company reimburses Copper Beech for the actual costs of fuel usage and the expenses of the pilots, landing fees, storage fees and similar expenses incurred during the trip. For the nine months ended September 30, 2020 and 2019, the aggregate amounts paid to Copper Beech for the use of the aircraft was $12 and $111, respectively. The Company leases 14 theatres and one parking facility from Syufy Enterprises, LP (“Syufy”) or affiliates of Syufy. Raymond Syufy is one of the Company’s directors and is an officer of the general partner of Syufy. Of these 15 leases, 14 have fixed minimum annual rent. The one lease without minimum annual rent has rent based upon a specified percentage of gross sales as defined in the lease. For the nine months ended September 30, 2020 and 2019, the Company paid total rent of approximately $17,271 and $20,006, respectively, to Syufy. The Company negotiated a deferral of rent payments for April, May and June of 2020 for 4 of the 14 leased theatres to be paid back over the months of July through December of 2020. The Company did not remeasure its lease liabilities and lease right-of-use assets as a result of these negotiations in accordance with FASB guidance. See further discussion at Note 4. The Company has a 50% voting interest in FE Concepts, a joint venture with AWSR, an entity owned by Lee Roy Mitchell and Tandy Mitchell. FE Concepts operates a family entertainment center that offers bowling, gaming, movies and other amenities that opened during December 2019. See Note 10 for further discussion. The Company has a theatre services agreement with FE Concepts under which the Company receives management fees for providing film booking and equipment monitoring services for the facility. The Company recorded $19 of management fees during the nine months ended September 30, 2020.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2020
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	19. Commitments and Contingencies From time to time, the Company is involved in various legal proceedings arising from the ordinary course of its business operations, such as personal injury claims, employment matters, patent claims, landlord-tenant disputes, contractual disputes with land lords over certain termination rights or the right to discontinue rent payments due to the COVID-19 pandemic and other contractual disputes, some of which are covered by insurance. The Company believes its potential liability with respect to proceedings cu rrently pending is not material, individually or in the aggregate, to the Company’s financial position, results of operations and cash flows. Intertrust Technologies Corporation (“Intertrust”) v. Cinemark Holdings, Inc., Regal, AMC, et al. This case was filed against the Company on August 7, 2019 in the Eastern District of Texas – Marshall Division alleging patent infringement. The Company firmly maintains that the contentions of the Plaintiff are without merit and will vigorously defend itself against the lawsuit. Although the Company does not believe that it has infringed on any of Intertrust’s patents, it cannot predict the outcome of this litigation. Flagship Theatres of Palm Desert, LLC d/b/a Cinemas Palme D’Or v. Century Theatres, Inc., and Cinemark USA, Inc.; Superior Court of the State of California, County of Los Angeles . Plaintiff in this case alleges that the Company violated California antitrust and unfair competition laws by engaging in “circuit dealing” with various motion picture distributors and tortiously interfered with Plaintiff’s business relationships. Plaintiff seeks compensatory damages, trebling of those damages under California law, punitive damages, injunctive relief, attorneys’ fees, costs and interest. Plaintiff also alleges that the Company’s conduct ultimately resulted in closure of its theatre in June 2016. The Company denied the allegations. In 2008, the Company moved for summary judgment on Plaintiff’s claims, arguing primarily that clearances between the theatres at issue were lawful and that Plaintiff lacked proof sufficient to support certain technical elements of its antitrust claims. The trial court granted that motion and dismissed Plaintiff’s claims. Plaintiff appealed and, in 2011, the Court of Appeal reversed, holding, among other things, that Plaintiff’s claims were not about the illegality of clearances but were focused, instead, on “circuit dealing.” Having re-framed the claims in that manner, the Court of Appeal held that the trial court’s decision to limit discovery to the market where the theatres at issue operated was an error, as “circuit dealing” necessarily involves activities in different markets. Upon return to the trial court, the parties engaged in additional, broadened discovery related to Plaintiff’s “circuit dealing” claim. Thereafter, the Company moved again for summary judgment on all of Plaintiff’s claims. That new motion for summary judgment was pending when, on or about April 11, 2014, the trial court granted the Company’s motion for terminating sanctions and entered a judgment dismissing the case with prejudice. Plaintiff then appealed that second dismissal, seeking to have the judgment reversed and the case remanded to the trial court. The Court of Appeal issued a ruling on May 24, 2016, reversing the granting of terminating sanctions and instead imposed a lesser evidentiary and damages preclusion sanction. The case returned to the trial court on October 6, 2016. On May 10, 2018, after a five-week jury trial, the jury found no liability on one circuit dealing claim and awarded Plaintiff damages on the other claim, which are tripled for antitrust damage awards. Plaintiff would also be entitled to certain court costs and to seek at least some portion of its attorney’s fees. During 2018, the Company recorded a litigation reserve based on the jury award, court costs and attorney’s fees. The trial court denied a motion for a judgment notwithstanding the verdict and a motion for a new trial. The Company appealed the judgment. On October 2, 2020 the Court of Appeals of the State of California reversed the judgement in favor of the Plaintiff and rendered judgement in favor of the Company. Plaintiff has agreed to not appeal this ruling to the California Supreme Court; therefore, the ruling in favor of the Company is final and non-appealable. The Company reversed the litigation reserve in the third quarter of 2020.

Impact of COVID-19 (Tables)

Impact of COVID-19 (Tables)	9 Months Ended
	Sep. 30, 2020
2020 Restructuring Plan
Unusual Or Infrequent Item [Line Items]
Schedule of Restructuring Plan and Obligations Remained Outstanding	The following table summarizes the costs of the 2020 Restructuring Plan, payments made, noncash write-offs and the remaining liability at September 30, 2020: U.S. Operating Segment International Operating Segment Consolidated Employee-related Costs Facility Closure Costs Total Charges Employee-related Costs Facility Closure Costs Total Charges Employee-related Costs Facility Closure Costs Total Charges Restructuring charges during the three months ended June 30, 2020 $ 8,955 $ 7,589 $ 16,544 $ 163 $ 2,831 $ 2,994 $ 9,118 $ 10,420 $ 19,538 Amounts paid (90 ) (482 ) (572 ) — (42 ) (42 ) (90 ) (524 ) (614 ) Noncash write-offs — 88 88 — (2,374 ) (2,374 ) — (2,286 ) (2,286 ) Reserve balance at June 30, 2020 $ 8,865 $ 7,195 $ 16,060 $ 163 $ 415 $ 578 $ 9,028 $ 7,610 $ 16,638 Restructuring charges during the three months ended September 30, 2020 (1) — 154 154 17 353 370 17 507 524 Amounts paid (6,521 ) (436 ) (6,957 ) (180 ) (313 ) (493 ) (6,701 ) (749 ) (7,450 ) Noncash write-offs — 47 47 — (129 ) (129 ) — (82 ) (82 ) Reserve balance at September 30, 2020 $ 2,344 $ 6,960 $ 9,304 $ — $ 326 $ 326 $ 2,344 $ 7,286 $ 9,630

Lease Accounting (Tables)

Lease Accounting (Tables)	9 Months Ended
	Sep. 30, 2020
Leases [Abstract]
Schedule of Aggregate Lease Costs by Lease Classification	The following table represents the Company’s aggregate lease costs, by lease classification, for the periods presented. Three Months Ended Nine Months Ended September 30 September 30 Lease Cost Classification 2020 2019 2020 2019 Operating lease costs Equipment (1) Utilities and other $ 823 $ 1,569 $ 2,495 $ 5,173 Real Estate (2)(3) Facility lease expense 65,970 88,149 211,088 262,783 Total operating lease costs $ 66,793 $ 89,718 $ 213,583 $ 267,956 Finance lease costs Amortization of leased assets Depreciation and amortization $ 3,665 $ 3,703 $ 11,052 $ 11,182 Interest on lease liabilities Interest expense 1,725 1,922 5,333 5,927 Total finance lease costs $ 5,390 $ 5,625 $ 16,385 $ 17,109 (1) Includes approximately $(267) and $452 of short-term lease payments for the three months ended September 30, 2020 and 2019, respectively. Includes approximately $(839) and $1,808 of short-term lease payments for the nine months ended September 30, 2020 and 2019, respectively. The amounts for the three and nine months ended September 30, 2020 were impacted by i) a decrease in short term lease payments while theatres were closed and ii) rent abatements on leases that were not recalculated in accordance with the FASB guidance discussed above, which resulted in variable rent credits in the amount of the rent abatements. (2) Includes approximately $(191) and $18,591 of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenues or attendance and variable common area maintenance costs for the three months ended September 30, 2020 and 2019, respectively. Includes approximately $9,146 and $54,209 of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenues or attendance and variable common area maintenance costs for the nine months ended September 30, 2020 and 2019. The amounts for the three and nine months ended September 30, 2020 were impacted by rent abatements on leases that were not recalculated in accordance with the FASB guidance discussed above, which resulted in variable rent credits in the amount of the rent abatements. (3) Approximately $335 and $400 of lease payments are included in general and administrative expenses primarily related to office leases for the three months ended September 30, 2020 and 2019, respectively. Approximately $1,122 and $1,184 of lease payments are included in general and administrative expenses primarily related to office leases for the nine months ended September 30, 2020 and 2019, respectively.
Schedule of Minimum Cash Lease Payments	The following table represents the minimum cash lease payments included in the measurement of lease liabilities and the non-cash addition of assets for the periods indicated. Nine Months Ended September 30, Other Information 2020 2019 Contractual cash payments included in the measurement of lease liabilities (1) Cash outflows for operating leases $ 205,276 $ 211,940 Cash outflows for finance leases - operating activities $ 5,304 $ 5,756 Cash outflows for finance leases - financing activities $ 11,497 $ 10,830 Non-cash amount of leased assets obtained in exchange for: Operating lease liabilities - real estate $ 84,209 $ 53,526 Operating lease liabilities - equipment $ 32 $ 668 Finance lease liabilities $ — $ —

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Sep. 30, 2020
Revenue From Contract With Customer [Abstract]
Summary of Revenues Disaggregated Based on Type of Good Or Service By Reportable Operating Segment and On Timing of Revenue Recognition	The following tables present revenues for the three and nine months ended September 30, 2020 and 2019, disaggregated based on major type of good or service and by reportable operating segment and disaggregated based on timing of revenue recognition. Three Months Ended Nine Months Ended September 30, 2020 September 30, 2020 U.S. International U.S. International Operating Operating Operating Operating Major Goods/Services Segment (1) Segment Consolidated Segment (1) Segment Consolidated Admissions revenues $ 14,794 $ 107 $ 14,901 $ 247,157 $ 60,243 $ 307,400 Concession revenues 8,861 255 9,116 161,674 37,922 199,596 Screen advertising, screen rental and promotional revenues (2) 9,227 513 9,740 35,319 13,437 48,756 Other revenues 1,527 194 1,721 25,857 6,459 32,316 Total revenues $ 34,409 $ 1,069 $ 35,478 $ 470,007 $ 118,061 $ 588,068 Three Months Ended Nine Months Ended September 30, 2019 September 30, 2019 U.S. International U.S. International Operating Operating Operating Operating Major Goods/Services Segment (1) Segment Consolidated Segment (1) Segment Consolidated Admissions revenues $ 351,122 $ 103,307 $ 454,429 $ 1,066,884 $ 304,157 $ 1,371,041 Concession revenues 230,415 59,062 289,477 704,727 181,356 886,083 Screen advertising, screen rental and promotional revenues 21,114 16,448 37,562 63,996 49,587 113,583 Other revenues 30,394 9,955 40,349 95,180 28,409 123,589 Total revenues $ 633,045 $ 188,772 $ 821,817 $ 1,930,787 $ 563,509 $ 2,494,296 Three Months Ended Nine Months Ended September 30, 2020 September 30, 2020 U.S. International U.S. International Operating Operating Operating Operating Timing of Recognition Segment (1) Segment Consolidated Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 24,945 $ 352 $ 25,297 $ 426,476 $ 101,681 $ 528,157 Goods and services transferred over time (2) 9,464 717 10,181 43,531 16,380 59,911 Total $ 34,409 $ 1,069 $ 35,478 $ 470,007 $ 118,061 $ 588,068 Three Months Ended Nine Months Ended September 30, 2019 September 30, 2019 U.S. International U.S. International Operating Operating Operating Operating Timing of Recognition Segment (1) Segment Consolidated Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 610,063 $ 169,171 $ 779,234 $ 1,860,828 $ 504,702 $ 2,365,530 Goods and services transferred over time 22,982 19,601 42,583 69,959 58,807 128,766 Total $ 633,045 $ 188,772 $ 821,817 $ 1,930,787 $ 563,509 $ 2,494,296 (1) U.S. segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 17 for additional information on intercompany eliminations. (2) Amount includes amortization of NCM screen advertising advances. See Deferred Revenues
Changes in Advances and Deferred Revenues	The following table presents changes in the Company’s advances and deferred revenues for the nine months ended September 30, 2020. NCM screen advertising advances (1) Other Deferred Revenues (2) Total Balance at January 1, 2020 $ 348,354 $ 138,426 $ 486,780 Amounts recognized as accounts receivable — 2,788 2,788 Cash received from customers in advance — 45,933 45,933 Common units received from NCM (see Note 9) 3,620 — 3,620 Interest accrued related to significant financing component 17,726 — 17,726 Revenue recognized during period (23,463 ) (44,714 ) (68,177 ) Foreign currency translation adjustments — (2,022 ) (2,022 ) Balance at September 30, 2020 $ 346,237 $ 140,411 $ 486,648 (1) See Note 9 for the maturity of balance as of September 30, 2020. (2) Includes liabilities associated with outstanding gift cards and discount ticket vouchers, points or rebates outstanding under the Company’s loyalty and membership programs and revenues not yet recognized for screen advertising, screen rental and other promotional activities. Classified as accounts payable and accrued expenses or other long-term liabilities on the condensed consolidated balance sheet.
Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized	The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of September 30, 2020 and when the Company expects to recognize this revenue. Twelve Months Ended September 30, Remaining Performance Obligations 2021 2022 2023 2024 2025 Thereafter Total Other Deferred revenue $ 125,429 $ 14,936 $ 46 $ — $ — $ — $ 140,411

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2020
Earnings Per Share [Abstract]
Earnings Per Share	The following table presents computations of basic and diluted earnings per share under the two-class method: Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Numerator: Net income (loss) attributable to Cinemark Holdings, Inc. $ (147,592 ) $ 31,353 $ (377,572 ) $ 165,052 Loss (earnings) allocated to participating share-based awards (1) 1,472 (211 ) 2,832 (1,012 ) Net income (loss) attributable to common stockholders $ (146,120 ) $ 31,142 $ (374,740 ) $ 164,040 Denominator (shares in thousands): Basic weighted average common stock outstanding 116,707 116,356 116,552 116,288 Common equivalent shares for restricted stock units (2) — 244 — 289 Diluted common equivalent shares 116,707 116,600 116,552 116,577 Basic earnings (loss) per share attributable to common stockholders $ (1.25 ) $ 0.27 $ (3.22 ) $ 1.41 Diluted earnings (loss) per share attributable to common stockholders $ (1.25 ) $ 0.27 $ (3.22 ) $ 1.41 (1) For the three months ended September 30, 2020 and 2019, a weighted average of approximately 1,175 and 793 shares of restricted stock, respectively, were considered participating securities. (2) For the three months ended September 30, 2020, approximately 438 common equivalent shares for restricted stock units were excluded because they were anti-dilutive. For the nine months ended September 30, 2020, approximately 689 common equivalent shares for restricted stock units were excluded because they were anti-dilutive.

Long Term Debt Activity (Tables

Long Term Debt Activity (Tables)	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Summary of Company's Interest Rate Swap Agreements Designated as Cash Flow Hedges	Below is a summary of the Company’s interest rate swap agreements designated as cash flow hedges as of September 30, 2020: Estimated Fair Value at Notional September 30, Amount Effective Date Pay Rate Receive Rate Expiration Date 2020 (1) $ 137,500 December 31, 2018 2.12% 1-Month LIBOR December 31, 2024 $ 10,719 $ 175,000 December 31, 2018 2.12% 1-Month LIBOR December 31, 2024 13,647 $ 137,500 December 31, 2018 2.19% 1-Month LIBOR December 31, 2024 11,192 $ 150,000 March 31, 2020 0.57% 1-Month LIBOR March 31, 2022 926 Total $ 36,484 (1) Approximately $9,763 of the total is included in accounts payable and accrued expenses and $26,721 is included in other long-term liabilities on the condensed consolidated balance sheet as of September 30, 2020.

Equity (Tables)

Equity (Tables)	9 Months Ended
	Sep. 30, 2020
Equity [Abstract]
Summary of Changes in Stockholders' Equity	Below is a summary of changes in stockholders’ equity attributable to Cinemark Holdings, Inc., noncontrolling interests and total equity for the three and nine months ended September 30, 2020 and 2019: Common Stock Treasury Stock Additional Paid-In-Capital Retained Earnings Accumulated Other Comprehensive Loss Total Cinemark Holdings, Inc. Stockholders’ Equity Noncontrolling Interests Total Equity Balance at January 1, 2020 $ 122 $ (81,567 ) $ 1,170,039 $ 687,332 $ (340,112 ) $ 1,435,814 $ 12,508 $ 1,448,322 Issuance of share based awards and share based awards compensation expense — — 4,111 — — 4,111 — 4,111 Stock withholdings related to share based awards that vested during the three months ended March 31, 2020 — (2,691 ) — — — (2,691 ) — (2,691 ) Dividends paid to stockholders, $0.36 per common share (1) — — — (42,311 ) — (42,311 ) — (42,311 ) Dividends paid to noncontrolling interests — — — — — — (392 ) (392 ) Dividends accrued on unvested restricted stock unit awards (1) — — — (256 ) — (256 ) — (256 ) Net income (loss) — — — (59,591 ) — (59,591 ) 169 (59,422 ) Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements — — — — (24,171 ) (24,171 ) — (24,171 ) Foreign currency translation adjustments — — — — (57,625 ) (57,625 ) — (57,625 ) Balance at March 31, 2020 122 (84,258 ) 1,174,150 585,174 (421,908 ) 1,253,280 12,285 1,265,565 Issuance of share based awards and share based awards compensation expense — — 4,321 — — 4,321 — 4,321 Stock withholdings related to share based awards that vested during the three months ended June 30, 2020 — (107 ) — — — (107 ) — (107 ) Net loss — — — (170,389 ) — (170,389 ) (427 ) (170,816 ) Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements — — — — 849 849 — 849 Amortization of accumulated losses for amended swap agreements — — — — 2,669 2,669 — 2,669 Foreign currency translation adjustments — — — — (3,702 ) (3,702 ) — (3,702 ) Balance at June 30, 2020 122 (84,365 ) 1,178,471 414,785 (422,092 ) 1,086,921 11,859 1,098,780 Issuance of share based awards and share based awards compensation expense 1 — 4,427 — 4,428 4,428 Stock withholdings related to share based awards that vested during the three months ended September 30, 2020 — (67 ) — — — (67 ) — (67 ) Net loss — — — (147,592 ) — (147,592 ) (444 ) (148,036 ) Issuance of convertible senior notes, net of allocated debt issue costs — — 97,359 — — 97,359 — 97,359 Tax impact of convertible notes issued — — 10,960 — — 10,960 — 10,960 Call options purchased — — (142,094 ) — — (142,094 ) — (142,094 ) Proceeds from issuance of warrants — — 89,424 — — 89,424 — 89,424 Unrealized gain to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements — — — — 6,528 6,528 — 6,528 Amortization of accumulated losses for amended swap agreements — — — — 2,669 2,669 — 2,669 Foreign currency translation adjustments — — — — (1,503 ) (1,503 ) — (1,503 ) Balance at September 30, 2020 $ 123 $ (84,432 ) $ 1,238,547 $ 267,193 $ (414,398 ) $ 1,007,033 $ 11,415 $ 1,018,448 Common Stock Treasury Stock Additional Paid-In-Capital Retained Earnings Accumulated Other Comprehensive Loss Total Cinemark Holdings, Inc. Stockholders’ Equity Noncontrolling Interests Total Equity Balance at January 1, 2019 $ 121 $ (79,259 ) $ 1,155,424 $ 686,459 $ (319,007 ) $ 1,443,738 $ 12,379 $ 1,456,117 Cumulative effect of change in accounting principle, net of taxes of $6,054 — — — 16,985 — 16,985 — 16,985 Issuance of share based awards and share based awards compensation expense — — 2,970 — 2,970 — 2,970 Stock withholdings related to share based awards that vested during the three months ended March 31, 2019 — (1,947 ) — — — (1,947 ) — (1,947 ) Dividends paid to stockholders, $0.34 per common share (1) — — — (39,797 ) — (39,797 ) — (39,797 ) Dividends paid to noncontrolling interests — — — — — — (1,000 ) (1,000 ) Dividends accrued on unvested restricted stock unit awards (1) — — — (108 ) — (108 ) — (108 ) Net income — — — 32,728 — 32,728 465 33,193 Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements — — — — (3,311 ) (3,311 ) — (3,311 ) Other comprehensive loss in equity method investees — — — — (71 ) (71 ) — (71 ) Foreign currency translation adjustments — — — — 755 755 — 755 Balance at March 31, 2019 121 (81,206 ) 1,158,394 696,267 (321,634 ) 1,451,942 11,844 1,463,786 Issuance of share based awards and share based awards compensation expense 1 — 3,676 — — 3,677 — 3,677 Stock withholdings related to share based awards that vested during the three months ended June 30, 2019 — (300 ) — — — (300 ) — (300 ) Dividends paid to stockholders, $0.34 per common share (1) — — — (39,823 ) — (39,823 ) — (39,823 ) Dividends paid to noncontrolling interests — — — — — — (294 ) (294 ) Dividends accrued on unvested restricted stock unit awards (1) — — — (189 ) — (189 ) — (189 ) Net income — — — 100,971 — 100,971 890 101,861 Other comprehensive loss in equity method investees — — — — (22 ) (22 ) — (22 ) Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements — — — — (5,902 ) (5,902 ) — (5,902 ) Foreign currency translation adjustments — — — — 4,925 4,925 — 4,925 Balance at June 30, 2019 $ 122 $ (81,506 ) $ 1,162,070 $ 757,226 $ (322,633 ) $ 1,515,279 $ 12,440 $ 1,527,719 Issuance of share based awards and share based awards compensation expense — — 3,840 — — 3,840 — 3,840 Dividends paid to stockholders, $0.34 per common share (1) — — — (39,832 ) — (39,832 ) — (39,832 ) Dividends paid to noncontrolling interests — — — — — — (294 ) (294 ) Dividends accrued on unvested restricted stock unit awards (1) — — — (189 ) — (189 ) — (189 ) Net income — — — 31,353 — 31,353 602 31,955 Other comprehensive loss in equity method investees — — — — (49 ) (49 ) — (49 ) Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements — — — — (1,291 ) (1,291 ) — (1,291 ) Foreign currency translation adjustments — — — — (25,408 ) (25,408 ) — (25,408 ) Balance at September 30, 2019 $ 122 $ (81,506 ) $ 1,165,910 $ 748,558 $ (349,381 ) $ 1,483,703 $ 12,748 $ 1,496,451 (1 ) Below is a summary of dividends paid to stockholders as well as dividends accrued on unvested restricted stock units during the nine months ended September 30, 2020 and 2019: Amount per Share Declaration Date Record Date Payable Date of Common Stock Total 2/21/2020 3/6/2020 3/20/2020 $ 0.36 $ 42,567 Nine Months Ended September 30, 2020 $ 0.36 $ 42,567 2/22/2019 3/8/2019 3/22/2019 $ 0.34 $ 39,905 5/23/2019 6/8/2019 6/24/2019 0.34 40,012 8/15/2019 9/4/2019 9/18/2019 0.34 40,021 Nine Months Ended September 30, 2019 $ 1.02 $ 119,938

National CineMedia (Tables)

National CineMedia (Tables)	9 Months Ended
	Sep. 30, 2020
Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized	The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of September 30, 2020 and when the Company expects to recognize this revenue. Twelve Months Ended September 30, Remaining Performance Obligations 2021 2022 2023 2024 2025 Thereafter Total Other Deferred revenue $ 125,429 $ 14,936 $ 46 $ — $ — $ — $ 140,411
NCM Screen Advertising Advances
Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized	The recognition of revenue related to the NCM screen advertising advances will be recorded on a straight-line basis through February 2041. Twelve Months Ended September 30, Remaining Maturity 2021 2022 2023 2024 2025 Thereafter Total NCM screen advertising advances $ 8,131 $ 8,693 $ 9,295 $ 9,940 $ 10,630 $ 299,548 $ 346,237
NCM
Summary of Activity With Equity Investee Included in the Company's Condensed Consolidated Financial Statements	Below is a summary of activity with NCM included in the Company’s condensed consolidated financial statements: Investment in NCM NCM Screen Advertising Advances Distributions from NCM Equity in Loss Other Revenue Interest Expense - NCM Cash Received Balance as of January 1, 2020 $ 265,792 $ (348,354 ) Receipt of common units due to annual common unit adjustment ("CUA") 3,620 (3,620 ) $ — $ — $ — $ — $ — Screen rental revenues earned under ESA (1) — — — — (4,209 ) — 4,209 Interest accrued related to significant financing component — (17,726 ) — — — 17,726 — Receipt of excess cash distributions (14,168 ) — (6,975 ) — — — 21,143 Equity in loss (4,810 ) — — 4,810 — — — Amortization of screen advertising advances — 23,463 — — (23,463 ) — — Balance as of and for the nine months ended September 30, 2020 $ 250,434 $ (346,237 ) $ (6,975 ) $ 4,810 $ (27,672 ) $ 17,726 $ 25,352 (1) Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire of approximately $2,243.
Summary Financial Information	NCM Financial Information Below is summary financial information for NCM for the periods indicated: Three Three Months ended Nine Months Ended Nine Months Ended September 24, 2020 September 26, 2019 September 24, 2020 September 26, 2019 Gross revenues $ 6,000 $ 110,513 $ 74,700 $ 297,613 Operating income (loss) $ (20,073 ) $ 39,349 $ (38,973 ) $ 87,949 Net income (loss) $ (34,950 ) $ 25,307 $ (81,350 ) $ 45,907 As of As of September 24, 2020 December 26, 2019 Current assets $ 170,749 $ 185,400 Noncurrent assets $ 693,018 $ 706,600 Current liabilities $ 47,153 $ 125,500 Noncurrent liabilities $ 1,073,742 $ 947,800 Members deficit $ (257,128 ) $ (181,300 )

Other Investments (Tables)

Other Investments (Tables)	9 Months Ended
	Sep. 30, 2020
Summary of Activity for Each of Company's Other Investments	Below is a summary of activity for each of the Company’s other investments for the nine months ended September 30, 2020: DCIP AC JV, LLC DCDC FE Concepts Other Total Balance at January 1, 2020 $ 124,696 $ 5,022 $ 3,169 $ 19,519 $ 2,879 $ 155,285 Cash distributions received (10,383 ) — (878 ) — — (11,261 ) Equity loss (20,083 ) (618 ) (1,197 ) (1,003 ) — (22,901 ) Other 50 — — — (2,584 ) (2,534 ) Balance at September 30, 2020 $ 94,280 $ 4,404 $ 1,094 $ 18,516 $ 295 $ 118,589
Digital Cinema Implementation Partners
Summary Financial Information	Below is summary financial information for DCIP for the periods indicated: Three Months Ended Nine Months Ended September 30, 2020 September 30, 2019 September 30, 2020 September 30, 2019 Gross revenues $ 1,084 $ 40,200 $ 20,809 $ 125,869 Operating income (loss) $ (29,878 ) $ 22,617 $ (72,422 ) $ 73,396 Net income (loss) $ (30,554 ) $ 22,362 $ (79,660 ) $ 69,323 As of September 30, 2020 December 31, 2019 Current assets $ 28,299 $ 51,382 Noncurrent assets $ 461,276 $ 581,547 Current liabilities $ 58,375 $ 70,515 Noncurrent liabilities $ 710 $ 190 Members' equity $ 430,490 $ 562,224
Transactions with DCIP	The Company had the following transactions with DCIP, reflected in utilities and other costs on the condensed consolidated statements of income, during the three and nine months ended September 30, 2020 and 2019: Three Months Ended Nine Months Ended September 30, 2020 September 30, 2019 September 30, 2020 September 30, 2019 Equipment lease payments (1) $ 346 $ 1,105 $ 1,384 $ 3,357 Warranty reimbursements from DCIP $ — $ (2,953 ) $ (3,123 ) $ (8,842 ) Management service fees $ — $ 128 $ 84 $ 438 (1) The Company negotiated an abatement of lease payments during the temporary closure of its theatres as a result of the COVID-19 pandemic. The Company did not remeasure its lease liabilities and lease right-of-use assets as a result of these negotiations in accordance with FASB guidance. See further discussion at Note 4.

Treasury Stock and Share Base_2

Treasury Stock and Share Based Awards (Tables)	9 Months Ended
	Sep. 30, 2020
Summary of Treasury Stock Activity	Below is a summary of the Company’s treasury stock activity for the nine months ended September 30, 2020: Number of Treasury Shares Cost Balance at January 1, 2020 4,711,859 $ 81,567 Restricted stock withholdings (1) 100,548 2,865 Restricted stock forfeitures 56,133 — Balance at September 30, 2020 4,868,540 $ 84,432 (1) The Company withheld restricted shares as a result of the election by certain employees to satisfy their tax liabilities upon vesting in restricted stock and restricted stock units. The Company determined the number of shares to be withheld based upon market values ranging from $8.03 to $32.12 per share.
Summary of Restricted Stock Activity	Below is a summary of restricted stock activity for the nine months ended September 30, 2020: Shares of Weighted Average Restricted Grant Date Stock Fair Value Outstanding at January 1, 2020 783,823 $ 37.53 Granted 1,045,885 $ 18.35 Vested (326,281 ) $ 35.63 Forfeited (56,133 ) $ 33.63 Outstanding at September 30, 2020 1,447,294 $ 24.25 Unvested restricted stock at September 30, 2020 1,447,294 $ 24.25
Summary of Potential Number of Shares that Could Vest Under Restricted Stock Unit Awards	Below is a table summarizing the potential number of shares that could vest under restricted stock unit awards granted during the nine months ended September 30, 2020 Number of Shares Value at Vesting Grant at IRR of at least 6% 190,707 $ 6,125 at IRR of at least 8% 286,060 $ 9,188 at IRR of at least 14% 436,681 $ 14,026
Restricted Stock
Summary of Restricted Stock and Restricted Stock Unit Award Activity	Nine Months Ended September 30, 2020 2019 Compensation expense recognized during the period $ 8,235 $ 7,456 Fair value of restricted shares that vested during the period $ 8,944 $ 7,630 Income tax benefit recognized upon vesting of restricted stock awards $ 2,678 $ 1,473
Restricted Stock Units (RSUs)
Summary of Restricted Stock and Restricted Stock Unit Award Activity	Nine Months Ended September 30, 2020 2019 Number of restricted stock unit awards that vested during the period 120,293 88,074 Fair value of restricted stock unit awards that vested during the period $ 3,669 $ 3,550 Accumulated dividends paid upon vesting of restricted stock unit awards $ 576 $ 375 Compensation expense recognized during the period $ 4,624 $ 3,030 Income tax benefit recognized upon vesting of restricted stock unit awards $ 215 $ 175

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Summary of Goodwill	A summary of the Company’s goodwill is as follows: U.S. Operating Segment International Operating Segment Total Balance at January 1, 2020 (1) $ 1,182,853 $ 100,518 $ 1,283,371 Impairment — (16,128 ) (16,128 ) Foreign currency translation adjustments — (17,816 ) (17,816 ) Balance at September 30, 2020 $ 1,182,853 $ 66,574 $ 1,249,427 (1) Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment. (2) See Note 13 for discussion of impairment evaluations performed during the nine months ended September 30, 2020.
Intangible Assets	A summary of the Company’s intangible assets is as follows: Balance at January 1, 2020 Amortization Other (1) Balance at September 30, 2020 Intangible assets with finite lives: Gross carrying amount $ 85,007 $ — $ (2,018 ) $ 82,989 Accumulated amortization (63,924 ) (3,569 ) — (67,493 ) Total net intangible assets with finite lives $ 21,083 $ (3,569 ) $ (2,018 ) $ 15,496 Intangible assets with indefinite lives: Tradename and other 300,686 — (613 ) 300,073 Total intangible assets — net $ 321,769 $ (3,569 ) $ (2,631 ) $ 315,569 (1) Amount primarily represents foreign currency translation adjustments.
Estimated Aggregate Future Amortization Expense for Intangible Assets	The estimated aggregate future amortization expense for intangible assets is as follows: For the three months ended December 31, 2020 $ 1,373 For the twelve months ended December 31, 2021 2,765 For the twelve months ended December 31, 2022 2,612 For the twelve months ended December 31, 2023 2,514 For the twelve months ended December 31, 2024 2,514 Thereafter 3,718 Total $ 15,496

Impairment of Long-Lived Asse_2

Impairment of Long-Lived Assets (Tables)	9 Months Ended
	Sep. 30, 2020
Impairment Or Disposal Of Tangible Assets Disclosure [Abstract]
Summary of Long Lived Asset Impairment Evaluations Performed by Assets Classification	The following table is a summary of the evaluations performed by asset classification. Impairment Asset Valuation Valuation Test Category Approach Multiple First Quarter Quantitative Goodwill Market (1) 8 times Tradename Intangible Assets Income N/A Other Long-lived Assets Market 6 times Second Quarter Qualitative Goodwill N/A N/A Tradename Intangible Assets N/A N/A Other Long-lived Assets N/A N/A Third Quarter Quantitative Goodwill Market (1) 2.9 to 7 times Tradename Intangible Assets Income N/A Other Long-lived Assets Market 3.2 to 6 times (1) The Company also used the income approach to test goodwill for impairment for the respective period.
Summary of Impairment Charges	The following table is a summary of the impairment recorded as a result of the evaluations discussed above during the three and nine months ended September 30, 2020: Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 U.S. Segment Theatre properties $ 2,075 $ 24,502 $ 5,718 $ 26,754 Theatre operating lease right-of-use assets 1,123 2,157 7,075 10,204 Cost method investment 2,500 — 2,500 — U.S. total 5,698 26,659 15,293 36,958 International segment Theatre properties 938 645 5,422 6,796 Theatre operating lease right-of-use assets 1,654 — 4,194 1,628 Goodwill 16,128 — 16,128 — Intangible assets 177 — 177 — International total 18,897 645 25,921 8,424 Total Impairment $ 24,595 $ 27,304 $ 41,214 $ 45,382

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Summary of Liabilities Measured at Fair Value on a Recurring Basis	Below is a summary of liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of September 30, 2020 and December 31, 2019: Carrying Fair Value Hierarchy Description As of, Value Level 1 Level 2 Level 3 Interest rate swap liabilities (1) September 30, 2020 $ 36,484 $ — $ 36,484 $ — Interest rate swap liabilities (1) December 31, 2019 $ 15,995 $ — $ 15,995 $ — (1) See further discussion of interest rate swaps at Note 7.

Foreign Currency Translation (T

Foreign Currency Translation (Tables)	9 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Summary of Impact of Translating Financial Statements of Company's International Subsidiaries	Below is a summary of the impact of translating the September 30, 2020 and 2019 financial statements of the Company’s international subsidiaries: Other Comprehensive Income (Loss) for Exchange Rate as of Nine Months Ended Country September 30, 2020 December 31, 2019 September 30, 2020 September 30, 2019 Brazil 5.63 4.02 $ (51,453 ) $ (14,492 ) Chile 785.93 736.86 (5,046 ) (4,017 ) Colombia 3,878.95 3,277.14 (2,584 ) (1,507 ) Peru 3.62 3.37 (3,187 ) (203 ) All other (560 ) 491 $ (62,830 ) $ (19,728 ) (1) Beginning July 1, 2018, Argentina was deemed highly inflationary. A gain of $1,053 and a loss of $3,356 for the nine months ended September 30, 2020 and 2019, respectively, is reflected as foreign currency exchange gain (loss) on the Company’s condensed consolidated statement of income as a result of translating Argentina financial results to U.S. dollars.

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information (Tables)	9 Months Ended
	Sep. 30, 2020
Supplemental Cash Flow Elements [Abstract]
Supplemental Information to Condensed Consolidated Statements of Cash Flows	The following is provided as supplemental information to the condensed consolidated statements of cash flows: Nine Months Ended September 30, 2020 2019 Cash paid for interest $ 53,364 $ 56,326 Cash paid (refunds received) for income taxes, net $ (108,776 ) $ 69,498 Noncash investing and financing activities: Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (1) $ (7,933 ) $ (13,642 ) Interest expense - NCM (see Note 9) $ (17,726 ) $ (14,180 ) Investment in NCM – receipt of common units (see Note 9) $ 3,620 $ 1,552 Dividends accrued on unvested restricted stock unit awards $ (257 ) $ (486 ) (1) Additions to theatre properties and equipment included in accounts payable as of September 30, 2020 and December 31, 2019 were $7,058 and $14,991, respectively.

Segments (Tables)

Segments (Tables)	9 Months Ended
	Sep. 30, 2020
Segment Reporting [Abstract]
Selected Financial Information by Reportable Operating Segment	Below is a breakdown of selected financial information by reportable operating segment: Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Revenues U.S. $ 34,639 $ 636,628 $ 472,096 $ 1,941,545 International 1,069 188,772 118,061 563,509 Eliminations (230 ) (3,583 ) (2,089 ) (10,758 ) Total revenues $ 35,478 $ 821,817 $ 588,068 $ 2,494,296 Adjusted EBITDA U.S. $ (105,767 ) $ 132,347 $ (145,947 ) $ 453,404 International (22,232 ) 37,411 (33,459 ) 113,346 Total Adjusted EBITDA $ (127,999 ) $ 169,758 $ (179,406 ) $ 566,750 Capital expenditures U.S. $ 17,903 $ 50,679 $ 54,604 $ 148,609 International 2,756 20,664 13,014 37,903 Total capital expenditures $ 20,659 $ 71,343 $ 67,618 $ 186,512
Reconciliation of Net Income (Loss) to Adjusted EBITDA	The following table sets forth a reconciliation of net income (loss) to Adjusted EBITDA: Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Net income (loss) $ (148,036 ) $ 31,955 $ (378,274 ) $ 167,009 Add (deduct): Income taxes (121,145 ) 14,053 (222,398 ) 64,152 Interest expense (1) 36,577 24,967 92,284 75,037 Other (income) expense, net (2) 22,881 (9,970 ) 47,385 (25,079 ) Cash distributions from DCIP (3) — 2,694 10,383 7,912 Cash distributions from other equity investees (4) 2,146 5,804 15,047 20,251 Depreciation and amortization 62,543 67,760 191,380 196,795 Impairment of long-lived assets 24,595 27,304 41,214 45,382 Restructuring costs 524 — 20,062 — (Gain) loss on disposal of assets and other (13,327 ) 2,453 (10,997 ) 8,057 Non-cash rent expense 816 (1,102 ) 1,649 (3,252 ) Share based awards compensation expense 4,427 3,840 12,859 10,486 Adjusted EBITDA $ (127,999 ) $ 169,758 $ (179,406 ) $ 566,750 (1) Includes amortization of debt issue costs and amortization of accumulated losses for amended swap agreements. (2) Includes interest income, foreign currency exchange gain (loss), equity in income of affiliates and interest expense - NCM and excludes distributions from NCM. (3) See discussion of cash distributions from DCIP, which were recorded as a reduction of the Company’s investment in DCIP, at Note 10. These distributions are reported entirely within the U.S. operating segment. (4) Includes cash distributions received from equity investees, other than those from DCIP noted above, that were recorded as a reduction of the respective investment balances (see Notes 9 and 10). These distributions are reported entirely within the U.S. operating segment.
Selected Financial Information by Geographic Area	Below is a breakdown of selected financial information by geographic area: Three Months Ended Nine Months Ended September 30, September 30, Revenues 2020 2019 2020 2019 U.S. $ 34,639 $ 636,628 $ 472,096 $ 1,941,545 Brazil 513 79,776 53,829 240,263 Other international countries 556 108,996 64,232 323,246 Eliminations (230 ) (3,583 ) (2,089 ) (10,758 ) Total $ 35,478 $ 821,817 $ 588,068 $ 2,494,296 As of As of Theatre Properties and Equipment-net September 30, 2020 December 31, 2019 U.S. $ 1,324,924 $ 1,436,275 Brazil 71,338 118,367 Other international countries 149,561 180,605 Total $ 1,545,823 $ 1,735,247

The Company and Basis of Pres_2

The Company and Basis of Presentation - Additional Information (Detail)	Sep. 30, 2020
Minimum
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Equity method investment, ownership percentage	20.00%
Maximum
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Equity method investment, ownership percentage	50.00%
Cost method investment, ownership Percentage	20.00%

Impact of COVID-19 - Additional

Impact of COVID-19 - Additional Information (Detail) $ in Thousands	3 Months Ended		9 Months Ended					12 Months Ended
	Sep. 30, 2020USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2020USD ($)Domestic	Sep. 30, 2020USD ($)International	Sep. 30, 2019USD ($)	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2020Domestic	Sep. 30, 2020International
Unusual Or Infrequent Item [Line Items]
Restructuring costs	$ 524		$ 20,062
Income taxes	(121,145)	$ 14,053	(222,398)				$ 64,152
Income (loss) income taxes	(269,181)	46,008	(600,672)				$ 231,161
Impact of COVID-19
Unusual Or Infrequent Item [Line Items]
Unpaid and accrued restructuring costs	9,630		9,630	$ 9,630	$ 9,630	$ 9,630
Impact of COVID-19
Unusual Or Infrequent Item [Line Items]
Number of domestic theaters reopened					252	15
Restructuring costs	524		20,062
Number of Theaters										14	7
Coronavirus Aid Relief And Economic Security Act | Impact of COVID-19
Unusual Or Infrequent Item [Line Items]
Income taxes	(121,145)	14,053	(222,398)
Income (loss) income taxes	$ (269,181)	$ 46,008
Effective income tax rate	45.00%	30.50%		35.00%				35.00%	35.00%
Income tax receivable	$ 84,105		84,105	$ 84,105	$ 84,105	$ 84,105
Income tax cash refunds			$ 115,769

Impact of COVID-19 - Schedule o

Impact of COVID-19 - Schedule of Restructuring Plan and Obligations Remained Outstanding (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Sep. 30, 2020
Unusual Or Infrequent Item [Line Items]
Restructuring costs	$ 524		$ 20,062
2020 Restructuring Plan | U.S. Operating Segment
Unusual Or Infrequent Item [Line Items]
Restructuring costs	154	$ 16,544
Amounts paid	(6,957)	(572)
Noncash write-offs	47	88
Reserve balance at June 30, 2020	9,304	16,060	9,304
2020 Restructuring Plan | U.S. Operating Segment | Employee Related
Unusual Or Infrequent Item [Line Items]
Restructuring costs		8,955
Amounts paid	(6,521)	(90)
Reserve balance at June 30, 2020	2,344	8,865	2,344
2020 Restructuring Plan | U.S. Operating Segment | Facility Closure Costs
Unusual Or Infrequent Item [Line Items]
Restructuring costs	154	7,589
Amounts paid	(436)	(482)
Noncash write-offs	47	88
Reserve balance at June 30, 2020	6,960	7,195	6,960
2020 Restructuring Plan | International Operating Segment
Unusual Or Infrequent Item [Line Items]
Restructuring costs	370	2,994
Amounts paid	(493)	(42)
Noncash write-offs	(129)	(2,374)
Reserve balance at June 30, 2020	326	578	326
2020 Restructuring Plan | International Operating Segment | Employee Related
Unusual Or Infrequent Item [Line Items]
Restructuring costs	17	163
Amounts paid	(180)
Reserve balance at June 30, 2020		163
2020 Restructuring Plan | International Operating Segment | Facility Closure Costs
Unusual Or Infrequent Item [Line Items]
Restructuring costs	353	2,831
Amounts paid	(313)	(42)
Noncash write-offs	(129)	(2,374)
Reserve balance at June 30, 2020	326	415	326
2020 Restructuring Plan | Consolidated
Unusual Or Infrequent Item [Line Items]
Restructuring costs	524	19,538
Amounts paid	(7,450)	(614)
Noncash write-offs	(82)	(2,286)
Reserve balance at June 30, 2020	9,630	16,638	9,630
2020 Restructuring Plan | Consolidated | Employee Related
Unusual Or Infrequent Item [Line Items]
Restructuring costs	17	9,118
Amounts paid	(6,701)	(90)
Reserve balance at June 30, 2020	2,344	9,028	2,344
2020 Restructuring Plan | Consolidated | Facility Closure Costs
Unusual Or Infrequent Item [Line Items]
Restructuring costs	507	10,420
Amounts paid	(749)	(524)
Noncash write-offs	(82)	(2,286)
Reserve balance at June 30, 2020	$ 7,286	$ 7,610	$ 7,286

Lease Accounting - Additional I

Lease Accounting - Additional Information (Detail) $ in Thousands	Sep. 30, 2020USD ($)Agreement
Theatres
Lease [Line Items]
Payments withheld or deferred classified as acounts payable and accrued expenses	$ 62,559
Noncancelable lease payments payable under operating lease, lease not yet commenced	$ 220,417
Equipment
Lease [Line Items]
Number of noncancelable lease agreements signed, but not yet commenced | Agreement	0

Schedule of Aggregate Lease Cos

Schedule of Aggregate Lease Costs by Lease Classification (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Operating lease costs
Total operating lease costs		$ 66,793	$ 89,718	$ 213,583	$ 267,956
Finance lease costs
Total finance lease costs		5,390	5,625	16,385	17,109
Depreciation and Amortization
Finance lease costs
Amortization of leased assets		3,665	3,703	11,052	11,182
Interest Expense
Finance lease costs
Interest on lease liabilities		1,725	1,922	5,333	5,927
Equipment | Utilities and Other
Operating lease costs
Total operating lease costs	[1]	823	1,569	2,495	5,173
Real Estate | Facility Lease Expense
Operating lease costs
Total operating lease costs	[2],[3]	$ 65,970	$ 88,149	$ 211,088	$ 262,783
[1]	Includes approximately $(267) and $452 of short-term lease payments for the three months ended September 30, 2020 and 2019, respectively.  Includes approximately $(839) and $1,808 of short-term lease payments for the nine months ended September 30, 2020 and 2019, respectively.  The amounts for the three and nine months ended September 30, 2020 were impacted by i) a decrease in short term lease payments while theatres were closed and ii) rent abatements on leases that were not recalculated in accordance with the FASB guidance discussed above, which resulted in variable rent credits in the amount of the rent abatements.
[2]	Approximately $335 and $400 of lease payments are included in general and administrative expenses primarily related to office leases for the three months ended September 30, 2020 and 2019, respectively.  Approximately $1,122 and $1,184 of lease payments are included in general and administrative expenses primarily related to office leases for the nine months ended September 30, 2020 and 2019, respectively.
[3]	Includes approximately $(191) and $18,591 of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenues or attendance and variable common area maintenance costs for the three months ended September 30, 2020 and 2019, respectively.  Includes approximately $9,146 and $54,209 of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenues or attendance and variable common area maintenance costs for the nine months ended September 30, 2020 and 2019.  The amounts for the three and nine months ended September 30, 2020 were impacted by rent abatements on leases that were not recalculated in accordance with the FASB guidance discussed above, which resulted in variable rent credits in the amount of the rent abatements.

Schedule of Aggregate Lease C_2

Schedule of Aggregate Lease Costs by Lease Classification (Parenthetical) (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Lease Cost [Line Items]
Lease payments			$ 205,276	$ 211,940
Equipment | Utilities and Other
Lease Cost [Line Items]
Short term lease payments	$ 267	$ 452	839	1,808
Real Estate | Facility Lease Expense
Lease Cost [Line Items]
Variable lease payments	191	18,591	9,146	54,209
Lease payments	$ 335	$ 400	$ 1,122	$ 1,184

Schedule of Minimum Cash Lease

Schedule of Minimum Cash Lease Payments (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Contractual cash payments included in the measurement of lease liabilities
Cash outflows for operating leases	$ 205,276	$ 211,940
Cash outflows for finance leases - operating activities	5,304	5,756
Cash outflows for finance leases - financing activities	11,497	10,830
Real Estate
Non-cash amount of leased assets obtained in exchange for:
Operating lease liabilities	84,209	53,526
Equipment
Non-cash amount of leased assets obtained in exchange for:
Operating lease liabilities	$ 32	$ 668

Revenue Recognition - Additiona

Revenue Recognition - Additional Information (Detail) - USD ($)	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019
Revenue From Contract With Customer [Abstract]
Receivables related to contracts with customers	$ 6,162,000	$ 31,620,000
Assets related to costs to obtain or fulfill contract with customers	$ 0		$ 0

Summary of Revenues Disaggregat

Summary of Revenues Disaggregated Based on Major Type of Good or Service and by Reportable Operating Segment (Detail) - USD ($) $ in Thousands		3 Months Ended			9 Months Ended
		Sep. 30, 2020		Sep. 30, 2019	Sep. 30, 2020		Sep. 30, 2019
Disaggregation of Revenue [Line Items]
Total revenues		$ 35,478		$ 821,817	$ 588,068		$ 2,494,296
Admissions Revenues
Disaggregation of Revenue [Line Items]
Total revenues		14,901		454,429	307,400		1,371,041
Concession Revenues
Disaggregation of Revenue [Line Items]
Total revenues		9,116		289,477	199,596		886,083
Screen Advertising, Screen Rental and Promotional Revenues
Disaggregation of Revenue [Line Items]
Total revenues		9,740	[1]	37,562	48,756	[1]	113,583
Other Revenues
Disaggregation of Revenue [Line Items]
Total revenues		1,721		40,349	32,316		123,589
U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[2]	34,409		633,045	470,007		1,930,787
U.S. Operating Segment | Admissions Revenues
Disaggregation of Revenue [Line Items]
Total revenues	[2]	14,794		351,122	247,157		1,066,884
U.S. Operating Segment | Concession Revenues
Disaggregation of Revenue [Line Items]
Total revenues	[2]	8,861		230,415	161,674		704,727
U.S. Operating Segment | Screen Advertising, Screen Rental and Promotional Revenues
Disaggregation of Revenue [Line Items]
Total revenues	[2]	9,227	[1]	21,114	35,319	[1]	63,996
U.S. Operating Segment | Other Revenues
Disaggregation of Revenue [Line Items]
Total revenues	[2]	1,527		30,394	25,857		95,180
International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		1,069		188,772	118,061		563,509
International Operating Segment | Admissions Revenues
Disaggregation of Revenue [Line Items]
Total revenues		107		103,307	60,243		304,157
International Operating Segment | Concession Revenues
Disaggregation of Revenue [Line Items]
Total revenues		255		59,062	37,922		181,356
International Operating Segment | Screen Advertising, Screen Rental and Promotional Revenues
Disaggregation of Revenue [Line Items]
Total revenues		513	[1]	16,448	13,437	[1]	49,587
International Operating Segment | Other Revenues
Disaggregation of Revenue [Line Items]
Total revenues		$ 194		$ 9,955	$ 6,459		$ 28,409
[1]	Amount includes amortization of NCM screen advertising advances. See Deferred Revenues
[2]	U.S. segment revenues include eliminations of intercompany transactions with the international operating segment.  See Note 17 for additional information on intercompany eliminations.

Summary of Revenues Disaggreg_2

Summary of Revenues Disaggregated Based on Timing of Revenue Recognition (Detail) - USD ($) $ in Thousands		3 Months Ended			9 Months Ended
		Sep. 30, 2020		Sep. 30, 2019	Sep. 30, 2020		Sep. 30, 2019
Disaggregation of Revenue [Line Items]
Total revenues		$ 35,478		$ 821,817	$ 588,068		$ 2,494,296
U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	34,409		633,045	470,007		1,930,787
International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		1,069		188,772	118,061		563,509
Goods and Services Transferred at a Point in Time
Disaggregation of Revenue [Line Items]
Total revenues		25,297		779,234	528,157		2,365,530
Goods and Services Transferred at a Point in Time | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	24,945		610,063	426,476		1,860,828
Goods and Services Transferred at a Point in Time | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		352		169,171	101,681		504,702
Goods and Services Transferred Over Time
Disaggregation of Revenue [Line Items]
Total revenues		10,181	[2]	42,583	59,911	[2]	128,766
Goods and Services Transferred Over Time | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	9,464	[2]	22,982	43,531	[2]	69,959
Goods and Services Transferred Over Time | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		$ 717	[2]	$ 19,601	$ 16,380	[2]	$ 58,807
[1]	U.S. segment revenues include eliminations of intercompany transactions with the international operating segment.  See Note 17 for additional information on intercompany eliminations.
[2]	Amount includes amortization of NCM screen advertising advances. See Deferred Revenues

Changes in Advances and Deferre

Changes in Advances and Deferred Revenues (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2020USD ($)
Change in Contract with Customer Liability [Line Items]
Balance at January 1, 2020	$ 486,780
Amounts recognized as accounts receivable	2,788
Cash received from customers in advance	45,933
Common units received from NCM (see Note 9)	3,620
Interest accrued related to significant financing component	17,726
Revenue recognized during period	(68,177)
Foreign currency translation adjustments	(2,022)
Balance at September 30, 2020	486,648
NCM
Change in Contract with Customer Liability [Line Items]
Interest accrued related to significant financing component	(17,726)
NCM Screen Advertising Advances
Change in Contract with Customer Liability [Line Items]
Balance at January 1, 2020	348,354	[1]
Common units received from NCM (see Note 9)	(3,620)
Interest accrued related to significant financing component	17,726	[1]
Revenue recognized during period	(23,463)	[1]
Balance at September 30, 2020	346,237	[1]
NCM Screen Advertising Advances | NCM
Change in Contract with Customer Liability [Line Items]
Common units received from NCM (see Note 9)	3,620	[1]
Other Deferred Revenues
Change in Contract with Customer Liability [Line Items]
Balance at January 1, 2020	138,426	[2]
Amounts recognized as accounts receivable	2,788	[2]
Cash received from customers in advance	45,933	[2]
Revenue recognized during period	(44,714)	[2]
Foreign currency translation adjustments	(2,022)	[2]
Balance at September 30, 2020	$ 140,411	[2]
[1]	See Note 9 for the maturity of balance as of September 30, 2020.
[2]	Includes liabilities associated with outstanding gift cards and discount ticket vouchers, points or rebates outstanding under the Company’s loyalty and membership programs and revenues not yet recognized for screen advertising, screen rental and other promotional activities. Classified as accounts payable and accrued expenses or other long-term liabilities on the condensed consolidated balance sheet.

Aggregate Amount of Transaction

Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized (Detail) $ in Thousands	Sep. 30, 2020USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2020-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2021-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period
Other Deferred Revenues
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 140,411
Other Deferred Revenues | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2020-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	125,429
Other Deferred Revenues | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2021-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	14,936
Other Deferred Revenues | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 46

Aggregate Amount of Transacti_2

Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized (Detail 1) $ in Thousands	Sep. 30, 2020USD ($)
Other Deferred Revenues
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 140,411

Computations of Basic and Dilut

Computations of Basic and Diluted Earnings Per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended			9 Months Ended
		Sep. 30, 2020	Sep. 30, 2019		Sep. 30, 2020	Sep. 30, 2019
Earnings Per Share Disclosure [Line Items]
Net income (loss) attributable to Cinemark Holdings, Inc.		$ (147,592)	$ 31,353		$ (377,572)	$ 165,052
Loss (earnings) allocated to participating share-based awards	[1]	1,472	(211)		2,832	(1,012)
Net income (loss) attributable to common stockholders		$ (146,120)	$ 31,142		$ (374,740)	$ 164,040
Basic weighted average common stock outstanding		116,707,000	116,356,000		116,552,000	116,288,000
Diluted common equivalent shares		116,707,000	116,600,000		116,552,000	116,577,000
Basic		$ (1.25)	$ 0.27		$ (3.22)	$ 1.41
Diluted		$ (1.25)	$ 0.27		$ (3.22)	$ 1.41
Restricted Stock Units (RSUs)
Earnings Per Share Disclosure [Line Items]
Common equivalent shares for restricted stock units		438,000	244,000	[2]	689,000	289,000	[2]
[1]	For the three months ended September 30, 2020 and 2019, a weighted average of approximately 1,175 and 793 shares of restricted stock, respectively, were considered participating securities.
[2]	For the three months ended September 30, 2020, approximately 438 common equivalent shares for restricted stock units were excluded because they were anti-dilutive.  For the nine months ended September 30, 2020, approximately 689 common equivalent shares for restricted stock units were excluded because they were anti-dilutive.

Computations of Basic and Dil_2

Computations of Basic and Diluted Earnings Per Share (Parenthetical) (Detail) - shares	3 Months Ended			9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019		Sep. 30, 2020	Sep. 30, 2019
Earnings Per Share Disclosure [Line Items]
Weighted average shares of participating restricted stock	1,175,000	793,000		880,000	719,000
Restricted Stock Units (RSUs)
Earnings Per Share Disclosure [Line Items]
Common equivalent shares for restricted stock units	438,000	244,000	[1]	689,000	289,000	[1]
[1]	For the three months ended September 30, 2020, approximately 438 common equivalent shares for restricted stock units were excluded because they were anti-dilutive.  For the nine months ended September 30, 2020, approximately 689 common equivalent shares for restricted stock units were excluded because they were anti-dilutive.

Earnings Per Share - Additional

Earnings Per Share - Additional Information (Detail) - 4.50 % Convertible Senior Notes - $ / shares	Sep. 30, 2020	Aug. 21, 2020
Earnings Per Share Disclosure [Line Items]
Interest rate	4.50%	4.50%
Warrants, per share	$ 22.08
Common shares issued	32,051,282

Long Term Debt Activity - Addit

Long Term Debt Activity - Additional Information (Detail)	Feb. 27, 2023USD ($)	Sep. 13, 2022USD ($)	Aug. 21, 2020USD ($)$ / shares	Apr. 20, 2020USD ($)	Mar. 25, 2020USD ($)	May 31, 2020USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2020USD ($)AgreementTradingDay	Dec. 31, 2019USD ($)
Debt Instrument [Line Items]
Quarterly principal payments due						$ 2,811,000		$ 4,357,000
Tax impact of conversion option and convertible note hedge and warrant transactions			$ 10,960,000
Percentage of principal amount of debt						1.00%
Debt Period, Start Date						Jul. 31, 2021		Dec. 31, 2020
Debt Period, End Date						Jun. 30, 2023		Sep. 30, 2025
Percentage of variable margin rate added to Colombian rate						7		9
Number of interest rate swap agreements amended and extended | Agreement								3
Carrying value of long-term debt							$ 2,412,891,000	$ 2,412,891,000	$ 1,801,327,000
Fair value of long-term debt							2,303,988,000	2,303,988,000	$ 1,826,503,000
Amortization of accumulated losses for amended swap agreements							2,669,000	5,338,000
Interest Rate Swap
Debt Instrument [Line Items]
Lass accumulated on swaps prior to the amendments							(29,359,000)	(29,359,000)
Senior Secured Credit Facility
Debt Instrument [Line Items]
Quarterly principal payments due								$ 1,649,000
Last quarterly payment date								Dec. 31, 2024
Final principal payment							$ 613,351,000	$ 613,351,000
4.50 % Convertible Senior Notes
Debt Instrument [Line Items]
Interest rate			4.50%				4.50%	4.50%
Trading price per principal amount of notes			$ 1,000
Percentage of product of last reported sale price of common stock and conversion rate			98.00%
Debt conversion, description								; (1) during the five business day period after any five consecutive trading day period, or the measurement period, in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on each such trading day; (2) if the Company distributes to all or substantially all stockholders (i) rights options or warrants entitling them to purchase shares at a discount to the recent average trading price of the Company’s common stock (including due to a stockholder rights plan) or (ii) the Company’s assets or securities or rights, options or warrants to purchase the same with a per share value exceeding 10% of the trading price of the Company’s stock, (3) upon the occurrence of specified corporate events as described further in the indenture, or (4) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price (initially 14.35 per share), on each applicable trading day. Beginning May 15, 2025, holders may convert their notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date. Upon conversion of the notes, the Company will pay or deliver cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock, at the Company’s election.
Debt instrument, convertible, latest date								May 15, 2025
Debt instrument, convertible, threshold trading days | TradingDay								20
Debt instrument, convertible, threshold consecutive trading days | TradingDay								30
Debt instrument, convertible, conversion ratio per 1000 principal amount			69.6767
Effective interest rate over contractual terms of notes to amortize debt discount to interest expense							10.00%	10.00%
Total cost of the Hedge Transactions			$ 142,094,000
Warrants, per share | $ / shares			$ 22.08
Cash proceeds from the sale of the warrants			$ 89,424,000
4.50 % Convertible Senior Notes | Minimum
Debt Instrument [Line Items]
Sale price per share | $ / shares			$ 14.35
Conversion price per share, percentage			130.00%
4.50 % Convertible Senior Notes | Cinemark Holdings Inc
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes			$ 460,000,000
Interest rate			4.50%
Debt instrument, maturity date			Aug. 15, 2025
8.750 % Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes				$ 250,000,000
Interest rate				8.75%
Debt instrument, maturity date				May 1, 2025
Price to repurchase the senior subordinated notes as a percentage of the aggregate principal amount outstanding plus accrued and unpaid interest in case of change of control								101.00%
5.125% Senior Notes | Scenario Forecast
Debt Instrument [Line Items]
Interest rate		5.125%
Debt instrument, maturity date		Sep. 14, 2022
Aggregate outstanding principal threshold amount if exceeds triggers maturity		$ 50,000,000
4.875% Senior Notes | Scenario Forecast
Debt Instrument [Line Items]
Interest rate	4.875%
Debt instrument, maturity date	Feb. 28, 2023
Aggregate outstanding principal threshold amount if exceeds triggers maturity	$ 50,000,000
Term Loan Credit facility | Senior Secured Credit Facility
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes							$ 700,000,000	$ 700,000,000
Amount outstanding under the term loan							$ 641,381,000	$ 641,381,000
Final principal payment due date								Mar. 29, 2025
Average interest rate on outstanding borrowings							3.40%	3.40%
Revolving Credit Line | Senior Secured Credit Facility
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes							$ 100,000,000	$ 100,000,000
Amount borrowed from revolving credit line					$ 98,800,000
Amount outstanding under the revolving credit line							0	0
Available borrowing capacity under the revolving credit line							$ 100,000,000	$ 100,000,000
Revolving credit line, maturity date								Nov. 28, 2022

Long Term Debt Activity - Summa

Long Term Debt Activity - Summary of Company's Interest Rate Swap Agreements Designated as Cash Flow Hedges (Detail) - Designated as Hedging Instrument - Cash Flow Hedging $ in Thousands	9 Months Ended
	Sep. 30, 2020USD ($)
Debt Instrument [Line Items]
Estimated Fair Value	$ 36,484	[1]
Interest Rate Swap Agreement 1
Debt Instrument [Line Items]
Notional Amount	$ 137,500
Effective Date	Dec. 31, 2018
Pay Rate	2.12%
Receive Rate	1-Month LIBOR
Expiration Date	Dec. 31, 2024
Estimated Fair Value	$ 10,719	[1]
Interest Rate Swap Agreement 2
Debt Instrument [Line Items]
Notional Amount	$ 175,000
Effective Date	Dec. 31, 2018
Pay Rate	2.12%
Receive Rate	1-Month LIBOR
Expiration Date	Dec. 31, 2024
Estimated Fair Value	$ 13,647	[1]
Interest Rate Swap Agreement 3
Debt Instrument [Line Items]
Notional Amount	$ 137,500
Effective Date	Dec. 31, 2018
Pay Rate	2.19%
Receive Rate	1-Month LIBOR
Expiration Date	Dec. 31, 2024
Estimated Fair Value	$ 11,192	[1]
Interest Rate Swap Agreement 4
Debt Instrument [Line Items]
Notional Amount	$ 150,000
Effective Date	Mar. 31, 2020
Pay Rate	0.57%
Receive Rate	1-Month LIBOR
Expiration Date	Mar. 31, 2022
Estimated Fair Value	$ 926	[1]
[1]	Approximately $9,763 of the total is included in accounts payable and accrued expenses and $26,721 is included in other long-term liabilities on the condensed consolidated balance sheet as of September 30, 2020.

Long Term Debt Activity - Sum_2

Long Term Debt Activity - Summary of Company's Interest Rate Swap Agreements Designated as Cash Flow Hedges (Parenthetical) (Detail) $ in Thousands	Sep. 30, 2020USD ($)
Accounts Payable and Accrued Expenses
Debt Instrument [Line Items]
Estimated Fair Value	$ 9,763
Other Long-term Liabilities
Debt Instrument [Line Items]
Estimated Fair Value	$ 26,721

Summary of Changes in Stockhold

Summary of Changes in Stockholders Equity (Detail) - USD ($) $ in Thousands		3 Months Ended										9 Months Ended
		Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020		Sep. 30, 2019		Jun. 30, 2019		Mar. 31, 2019		Sep. 30, 2020	Sep. 30, 2019
Shareholders Equity [Line Items]
Total Equity, Beginning Balance		$ 1,098,780	$ 1,265,565	$ 1,448,322		$ 1,527,719		$ 1,463,786		$ 1,456,117		$ 1,448,322	$ 1,456,117
Issuance of share based awards and share based awards compensation expense		4,428	4,321	4,111		3,840		3,677		2,970
Stock withholdings related to share based awards that vested		(67)	(107)	(2,691)				(300)		(1,947)
Dividends paid to stockholders	[1]			(42,311)		(39,832)		(39,823)		(39,797)
Dividends paid to noncontrolling interests				(392)		(294)		(294)		(1,000)
Dividends accrued on unvested restricted stock unit awards				(256)	[1]	(189)	[1]	(189)	[1]	(108)	[1]	(257)	(486)
Net income (loss)		(148,036)	(170,816)	(59,422)		31,955		101,861		33,193		(378,274)	167,009
Issuance of convertible senior notes		97,359
Tax impact of convertible notes issued		10,960
Call options purchased		(142,094)
Proceeds from issuance of warrants		89,424
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements		6,528	849	(24,171)		(1,291)		(5,902)		(3,311)		(16,794)	(10,504)
Other comprehensive loss in equity method investments		0				(49)		(22)		(71)		0	(142)
Amortization of accumulated losses for amended swap agreements		2,669	2,669
Foreign currency translation adjustments		(1,503)	(3,702)	(57,625)		(25,408)		4,925		755
Total Equity, Ending Balance		1,018,448	1,098,780	1,265,565		1,496,451		1,527,719		1,463,786		1,018,448	1,496,451
Cumulative Effect, Period of Adoption, Adjustment
Shareholders Equity [Line Items]
Cumulative effect of change in accounting principle, net of taxes										16,985
Common Stock
Shareholders Equity [Line Items]
Total Equity, Beginning Balance		122	122	122		122		121		121		122	121
Issuance of share based awards and share based awards compensation expense		1						1
Total Equity, Ending Balance		123	122	122		122		122		121		123	122
Treasury Stock
Shareholders Equity [Line Items]
Total Equity, Beginning Balance		(84,365)	(84,258)	(81,567)		(81,506)		(81,206)		(79,259)		(81,567)	(79,259)
Stock withholdings related to share based awards that vested		(67)	(107)	(2,691)				(300)		(1,947)
Total Equity, Ending Balance		(84,432)	(84,365)	(84,258)		(81,506)		(81,506)		(81,206)		(84,432)	(81,506)
Additional Paid-In-Capital
Shareholders Equity [Line Items]
Total Equity, Beginning Balance		1,178,471	1,174,150	1,170,039		1,162,070		1,158,394		1,155,424		1,170,039	1,155,424
Issuance of share based awards and share based awards compensation expense		4,427	4,321	4,111		3,840		3,676		2,970
Issuance of convertible senior notes		97,359
Tax impact of convertible notes issued		10,960
Call options purchased		(142,094)
Proceeds from issuance of warrants		89,424
Total Equity, Ending Balance		1,238,547	1,178,471	1,174,150		1,165,910		1,162,070		1,158,394		1,238,547	1,165,910
Retained Earnings
Shareholders Equity [Line Items]
Total Equity, Beginning Balance		414,785	585,174	687,332		757,226		696,267		686,459		687,332	686,459
Dividends paid to stockholders	[1]			(42,311)		(39,832)		(39,823)		(39,797)
Dividends accrued on unvested restricted stock unit awards	[1]			(256)		(189)		(189)		(108)
Net income (loss)		(147,592)	(170,389)	(59,591)		31,353		100,971		32,728
Total Equity, Ending Balance		267,193	414,785	585,174		748,558		757,226		696,267		267,193	748,558
Retained Earnings | Cumulative Effect, Period of Adoption, Adjustment
Shareholders Equity [Line Items]
Cumulative effect of change in accounting principle, net of taxes										16,985
Accumulated Other Comprehensive Loss
Shareholders Equity [Line Items]
Total Equity, Beginning Balance		(422,092)	(421,908)	(340,112)		(322,633)		(321,634)		(319,007)		(340,112)	(319,007)
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements		6,528	849	(24,171)		(1,291)		(5,902)		(3,311)
Other comprehensive loss in equity method investments						(49)		(22)		(71)
Amortization of accumulated losses for amended swap agreements		2,669	2,669
Foreign currency translation adjustments		(1,503)	(3,702)	(57,625)		(25,408)		4,925		755
Total Equity, Ending Balance		(414,398)	(422,092)	(421,908)		(349,381)		(322,633)		(321,634)		(414,398)	(349,381)
Total Cinemark Holdings, Inc.'s Stockholders' Equity
Shareholders Equity [Line Items]
Total Equity, Beginning Balance		1,086,921	1,253,280	1,435,814		1,515,279		1,451,942		1,443,738		1,435,814	1,443,738
Issuance of share based awards and share based awards compensation expense		4,428	4,321	4,111		3,840		3,677		2,970
Stock withholdings related to share based awards that vested		(67)	(107)	(2,691)				(300)		(1,947)
Dividends paid to stockholders	[1]			(42,311)		(39,832)		(39,823)		(39,797)
Dividends accrued on unvested restricted stock unit awards	[1]			(256)		(189)		(189)		(108)
Net income (loss)		(147,592)	(170,389)	(59,591)		31,353		100,971		32,728
Issuance of convertible senior notes		97,359
Tax impact of convertible notes issued		10,960
Call options purchased		(142,094)
Proceeds from issuance of warrants		89,424
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes, net of settlements		6,528	849	(24,171)		(1,291)		(5,902)		(3,311)
Other comprehensive loss in equity method investments						(49)		(22)		(71)
Amortization of accumulated losses for amended swap agreements		2,669	2,669
Foreign currency translation adjustments		(1,503)	(3,702)	(57,625)		(25,408)		4,925		755
Total Equity, Ending Balance		1,007,033	1,086,921	1,253,280		1,483,703		1,515,279		1,451,942		1,007,033	1,483,703
Total Cinemark Holdings, Inc.'s Stockholders' Equity | Cumulative Effect, Period of Adoption, Adjustment
Shareholders Equity [Line Items]
Cumulative effect of change in accounting principle, net of taxes										16,985
Noncontrolling Interests
Shareholders Equity [Line Items]
Total Equity, Beginning Balance		11,859	12,285	12,508		12,440		11,844		12,379		12,508	12,379
Dividends paid to noncontrolling interests				(392)		(294)		(294)		(1,000)
Net income (loss)		(444)	(427)	169		602		890		465
Total Equity, Ending Balance		$ 11,415	$ 11,859	$ 12,285		$ 12,748		$ 12,440		$ 11,844		$ 11,415	$ 12,748
[1]	Below is a summary of dividends paid to stockholders as well as dividends accrued on unvested restricted stock units during the nine months ended September 30, 2020 and 2019

Summary of Changes in Stockho_2

Summary of Changes in Stockholders Equity (Parenthetical) (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				9 Months Ended
	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019
Shareholders Equity [Line Items]
Dividends paid to stockholders, per share	$ 0.36	$ 0.34	$ 0.34	$ 0.34
Cumulative effect of change in accounting principle, taxes				$ 6,054
Amount per Share of Common Stock						$ 1.02
Total						$ 119,938
First Quarter Dividend
Shareholders Equity [Line Items]
Declaration Date					Feb. 21, 2020	Feb. 22, 2019
Record Date					Mar. 6, 2020	Mar. 8, 2019
Payable Date					Mar. 20, 2020	Mar. 22, 2019
Amount per Share of Common Stock					$ 0.36	$ 0.34
Total					$ 42,567	$ 39,905
Second Quarter Dividend
Shareholders Equity [Line Items]
Declaration Date						May 23, 2019
Record Date						Jun. 8, 2019
Payable Date						Jun. 24, 2019
Amount per Share of Common Stock						$ 0.34
Total						$ 40,012
Third Quarter Dividend
Shareholders Equity [Line Items]
Declaration Date						Aug. 15, 2019
Record Date						Sep. 4, 2019
Payable Date						Sep. 18, 2019
Amount per Share of Common Stock						$ 0.34
Total						$ 40,021

Summary of Activity with NCM In

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Schedule Of Equity Method Investments [Line Items]
Receipt of common units due to annual common unit adjustment ("CUA")				$ 3,620
Equity in loss		$ (16,077)	$ 15,139	(27,711)	$ 33,982
Investment In NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance				265,792
Receipt of common units due to annual common unit adjustment ("CUA")				3,620
Receipt of excess cash distributions				(14,168)
Equity in loss				(4,810)
Ending Balance		250,434		250,434
NCM Screen Advertising Advances
Schedule Of Equity Method Investments [Line Items]
Beginning Balance				(348,354)
Receipt of common units due to annual common unit adjustment ("CUA")				(3,620)
Interest accrued related to significant financing component				(17,726)
Amortization of screen advertising advances				23,463
Ending Balance		(346,237)		(346,237)
Distributions from NCM
Schedule Of Equity Method Investments [Line Items]
Receipt of excess cash distributions				(6,975)
Total Distributions from NCM		(6,975)		(6,975)
Equity in Loss
Schedule Of Equity Method Investments [Line Items]
Equity in loss				4,810
Ending Balance		4,810		4,810
Other Revenues
Schedule Of Equity Method Investments [Line Items]
Screen rental revenues earned under ESA	[1]			(4,209)
Amortization of screen advertising advances				(23,463)
Total Revenues		(27,672)		(27,672)
Interest Expense - NCM
Schedule Of Equity Method Investments [Line Items]
Interest accrued related to significant financing component				17,726
Total noncash interest expense accrued related to NCM screen advertising advances		17,726		17,726
Cash Received
Schedule Of Equity Method Investments [Line Items]
Screen rental revenues earned under ESA	[1]			4,209
Receipt of excess cash distributions				21,143
Total cash received from NCM		$ 25,352		$ 25,352
[1]	Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire of approximately $2,243.

Summary of Activity with NCM _2

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Parenthetical) (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2020USD ($)
Equity Method Investments And Joint Ventures [Abstract]
Company's beverage concessionaire advertising costs	$ 2,243

National CineMedia - Additional

National CineMedia - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2020USD ($)$ / sharesshares	Sep. 30, 2019USD ($)	Dec. 31, 2019USD ($)
Schedule Of Equity Method Investments [Line Items]
Number of additional common units of NCM received under common unit adjustment agreement | shares	1,112,368
Value of common units received from NCM	$ 3,620,000	$ 1,552,000
Number of common units of NCM owned by Company | shares	40,850,068
Interest in common units of NCM owned by Company	25.00%
Investment In NCM
Schedule Of Equity Method Investments [Line Items]
Common unit convertible into share of NCMI common stock, conversion ratio	1
Estimated fair value of investment using NCM's stock price	$ 111,112,000
NCMI common stock price | $ / shares	$ 2.72
Investment in NCM	$ 250,434,000		$ 265,792,000
NCM
Schedule Of Equity Method Investments [Line Items]
Proceeds from ESA Modification	$ 174,000,000
Deferred revenue amortization year and month	2041-02
Investment in NCM	$ 250,434,000		$ 265,792,000
Impairment of investment	$ 0
Deferred revenue or NCM screen advertising advances extended term	2041-02
Recognized incremental screen rental revenue and offsetting interest expense		$ 17,726,000
Amortization of screen advertising advances	$ 23,463,000
NCM | Minimum
Schedule Of Equity Method Investments [Line Items]
Percentage of incremental borrowing rates	4.40%
NCM | Maximum
Schedule Of Equity Method Investments [Line Items]
Percentage of incremental borrowing rates	8.30%

Summary of Recognition of Reven

Summary of Recognition of Revenue Related To Deferred Revenue (Detail) $ in Thousands	Sep. 30, 2020USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2020-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2021-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-04-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period
NCM Screen Advertising Advances
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue remaining performance obligation, amount	$ 346,237
NCM Screen Advertising Advances | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2021-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue remaining performance obligation, amount	$ 8,131
NCM Screen Advertising Advances | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue remaining performance obligation, amount	$ 8,693
NCM Screen Advertising Advances | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue remaining performance obligation, amount	$ 9,295
NCM Screen Advertising Advances | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue remaining performance obligation, amount	$ 9,940
NCM Screen Advertising Advances | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue remaining performance obligation, amount	$ 10,630
NCM Screen Advertising Advances | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2026-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period
Revenue remaining performance obligation, amount	$ 299,548

Summary of Recognition of Rev_2

Summary of Recognition of Revenue Related To Deferred Revenue (Detail 1) $ in Thousands	Sep. 30, 2020USD ($)
NCM Screen Advertising Advances
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue remaining performance obligation, amount	$ 346,237

Summary Financial Information f

Summary Financial Information for National CineMedia (Detail) - USD ($) $ in Thousands	3 Months Ended				9 Months Ended
	Sep. 30, 2020	Sep. 24, 2020	Sep. 30, 2019	Sep. 26, 2019	Sep. 30, 2020	Sep. 24, 2020	Sep. 30, 2019	Sep. 26, 2019	Dec. 31, 2019	Dec. 26, 2019
Schedule Of Equity Method Investments [Line Items]
Operating income (loss)	$ (210,784)		$ 58,531		$ (467,978)		$ 271,951
Net income (loss) attributable to Cinemark Holdings, Inc.	(147,592)		$ 31,353		(377,572)		$ 165,052
Deferred charges and other assets, net	36,047				36,047				$ 39,114
Current liabilities	623,877				623,877				708,800
Noncurrent liabilities	$ 4,160,288				$ 4,160,288				$ 3,670,895
NCM
Schedule Of Equity Method Investments [Line Items]
Gross revenues		$ 6,000		$ 110,513		$ 74,700		$ 297,613
Operating income (loss)		(20,073)		39,349		(38,973)		87,949
Net income (loss) attributable to Cinemark Holdings, Inc.		(34,950)		$ 25,307		(81,350)		$ 45,907
Current assets		170,749				170,749				$ 185,400
Deferred charges and other assets, net		693,018				693,018				706,600
Current liabilities		47,153				47,153				125,500
Noncurrent liabilities		1,073,742				1,073,742				947,800
Members deficit		$ (257,128)				$ (257,128)				$ (181,300)

Summary of Activity for Each of

Summary of Activity for Each of Company's Other Investments (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				$ 155,285
Cash distributions received				(25,430)	$ (28,163)
Equity in loss		$ (16,077)	$ 15,139	(27,711)	33,982
Investments, ending balance		118,589		118,589
Digital Cinema Implementation Partners
Schedule Of Equity Method Investments [Line Items]
Cash distributions received	[1]		$ (2,694)	(10,383)	$ (7,912)
Other Affiliates
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				155,285
Cash distributions received				(11,261)
Equity in loss				(22,901)
Other				(2,534)
Investments, ending balance		118,589		118,589
Other Affiliates | Digital Cinema Implementation Partners
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				124,696
Cash distributions received				(10,383)
Equity in loss				(20,083)
Other				50
Investments, ending balance		94,280		94,280
Other Affiliates | AC JV, LLC
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				5,022
Equity in loss				(618)
Investments, ending balance		4,404		4,404
Other Affiliates | Digital Cinema Distribution Coalition
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				3,169
Cash distributions received				(878)
Equity in loss				(1,197)
Investments, ending balance		1,094		1,094
Other Affiliates | FE Concepts, LLC
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				19,519
Equity in loss				(1,003)
Investments, ending balance		18,516		18,516
Other Affiliates | Other Investments
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				2,879
Other				(2,584)
Investments, ending balance		$ 295		$ 295
[1]	See discussion of cash distributions from DCIP, which were recorded as a reduction of the Company’s investment in DCIP, at Note 10. These distributions are reported entirely within the U.S. operating segment.

Other Investments - Additional

Other Investments - Additional Information (Detail) $ in Thousands	Apr. 30, 2018USD ($)	Sep. 30, 2020USD ($)ProjectionSystem	Sep. 30, 2019USD ($)	Sep. 30, 2020USD ($)StudioProjectionSystem	Sep. 30, 2019USD ($)
Schedule Of Equity Method Investments [Line Items]
Total revenues		$ 35,478	$ 821,817	$ 588,068	$ 2,494,296
Maximum
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest		50.00%		50.00%
Minimum
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest		20.00%		20.00%
Digital Cinema Implementation Partners
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest		33.00%		33.00%
Economic interest in Digital Cinema Implementation Partners		24.30%		24.30%
Description of digital cinema deployment agreements				The DCDAs end on the earlier to occur of (i) the tenth anniversary of the "mean deployment date" for all digital projection systems scheduled to be deployed over a period of up to five years, or (ii) the date DCIP achieves "cost recoupment", each as defined in the DCDAs.
Number of major motion picture studio, long-term digital cinema deployment agreements | Studio				6
Number of equipment being leased under master equipment lease agreement | ProjectionSystem		3,812		3,812
Digital Cinema Implementation Partners | Maximum
Schedule Of Equity Method Investments [Line Items]
Deployment period of digital cinema deployment agreements				5 years
AC JV, LLC | Film rentals and advertising
Schedule Of Equity Method Investments [Line Items]
Event fees				$ 2,258	10,332
Digital Cinema Distribution Coalition
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest		14.60%		14.60%
Payments for content delivery services				$ 208	$ 703
CNMK Texas Properties, LLC
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest	50.00%
Cash contributions	$ 20,000
CNMK Texas Properties, LLC | AWSR Investments, LLC
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest	50.00%
Cash contributions	$ 20,000
CNMK Texas Properties, LLC | AWSR Investments, LLC | Theatre Services
Schedule Of Equity Method Investments [Line Items]
Total revenues		$ 3		$ 19

Summary Financial Information_2

Summary Financial Information for DCIP (Detail) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Dec. 31, 2018
Schedule Of Equity Method Investments [Line Items]
Net income (loss)	$ (148,036)	$ (170,816)	$ (59,422)	$ 31,955	$ 101,861	$ 33,193	$ (378,274)	$ 167,009
Current assets	984,009						984,009		$ 634,990
Current liabilities	623,877						623,877		708,800
Noncurrent liabilities	4,160,288						4,160,288		3,670,895
Members' equity	1,018,448	$ 1,098,780	$ 1,265,565	1,496,451	$ 1,527,719	$ 1,463,786	1,018,448	1,496,451	1,448,322	$ 1,456,117
Other Affiliates | Digital Cinema Implementation Partners
Schedule Of Equity Method Investments [Line Items]
Gross revenues	1,084			40,200			20,809	125,869
Operating income (loss)	(29,878)			22,617			(72,422)	73,396
Net income (loss)	(30,554)			$ 22,362			(79,660)	$ 69,323
Current assets	28,299						28,299		51,382
Noncurrent assets	461,276						461,276		581,547
Current liabilities	58,375						58,375		70,515
Noncurrent liabilities	710						710		190
Members' equity	$ 430,490						$ 430,490		$ 562,224

Transactions with DCIP (Detail)

Transactions with DCIP (Detail) - Digital Cinema Implementation Partners - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Schedule Of Equity Method Investments [Line Items]
Equipment lease payments	[1]	$ 346	$ 1,105	$ 1,384	$ 3,357
Warranty reimbursements from DCIP			(2,953)	(3,123)	(8,842)
Management service fees			$ 128	$ 84	$ 438
[1]	(1) The Company negotiated an abatement of lease payments during the temporary closure of its theatres as a result of the COVID-19 pandemic. The Company did not remeasure its lease liabilities and lease right-of-use assets as a result of these negotiations in accordance with FASB guidance. See further discussion at Note 4.

Summary of Treasury Stock Activ

Summary of Treasury Stock Activity (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2020USD ($)shares
Treasury Stock Shares [Abstract]
Beginning Balance, Shares | shares	4,711,859
Restricted stock withholdings | shares	100,548	[1]
Restricted stock forfeitures | shares	56,133
Ending Balance, Shares | shares	4,868,540
Beginning Balance, Cost | $	$ 81,567
Restricted stock withholdings | $	2,865	[1]
Restricted stock forfeitures | $	0
Ending Balance, Cost | $	$ 84,432
[1]	The Company withheld restricted shares as a result of the election by certain employees to satisfy their tax liabilities upon vesting in restricted stock and restricted stock units.  The Company determined the number of shares to be withheld based upon market values ranging from $8.03 to $32.12 per share.

Summary of Treasury Stock Act_2

Summary of Treasury Stock Activity (Parenthetical) (Detail)	9 Months Ended
	Sep. 30, 2020$ / shares
Minimum
Schedule of Treasury Stock [Line Items]
Market Value of Restricted Shares	$ 8.03
Maximum
Schedule of Treasury Stock [Line Items]
Market Value of Restricted Shares	$ 32.12

Treasury Stock and Share Base_3

Treasury Stock and Share Based Awards - Additional Information (Detail) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2020USD ($)$ / sharesshares
Restricted Stock
Stockholders Equity Note [Line Items]
Number of restricted shares granted | shares	1,045,885
Market value of common stock on the dates of grant	$ 18.35
Restricted Stock | Minimum
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant	$ 8.39
Forfeiture rate for restricted stock awards	0.00%
Award vesting period for restricted stock	1 year
Restricted Stock | Maximum
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant	$ 32.12
Forfeiture rate for restricted stock awards	10.00%
Award vesting period for restricted stock	4 years
Unvested Restricted Stock Awards
Stockholders Equity Note [Line Items]
Unrecognized compensation expense | $	$ 22,858
Remaining compensation expense recognition period (in years)	2 years
Restricted Stock Units (RSUs)
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant	$ 32.12
Unrecognized compensation expense | $	$ 13,559
Remaining compensation expense recognition period (in years)	2 years
Number of hypothetical shares of common stock | shares	436,681
Share-based compensation arrangement by share-based payment award, description	The financial performance factors are based on an implied equity value concept that determines an internal rate of return (“IRR”) during the two fiscal year periods ending December 31, 2021 based on a formula utilizing a multiple of Adjusted EBITDA subject to certain adjustments as specified by the Compensation Committee prior to the grant date
Internal rate of return, performance period	2 years
Percentage of IRR, which is the threshold	6.00%
Percentage of IRR, which is the target	8.00%
Percentage of IRR, which is the maximum	14.00%
Percentage of IRR expected	11.00%
Share-based compensation arrangement by share-based payment award, vesting condition	All restricted stock units granted during 2020 will vest subject to an additional two-year service requirement and will be paid in the form of common stock if the participant continues to provide services through the fourth anniversary of the grant date
Expected forfeiture rate	5.00%
Number of hypothetical shares of common stock at IRR levels | shares	978,591
Restricted Stock Units (RSUs) | Stock Grants 2018
Stockholders Equity Note [Line Items]
Achieved percentage of IRR	8.60%
Restricted Stock Units (RSUs) | Stock Grants 2017
Stockholders Equity Note [Line Items]
Achieved percentage of IRR	9.30%
Restricted Stock Units (RSUs) | ASC Topic 718
Stockholders Equity Note [Line Items]
Weighted average grant date fair value per share as of date of modification	$ 15.95
Incremental stock-based compensation expense arising from the modification | $	$ 521
Restricted Stock Units (RSUs) | Maximum | Threshold IRR
Stockholders Equity Note [Line Items]
Vesting percentage of restricted stock units	33.33%
Restricted Stock Units (RSUs) | Maximum | Targeted IRR
Stockholders Equity Note [Line Items]
Vesting percentage of restricted stock units	66.66%
Restricted Stock Units (RSUs) | Maximum | Maximum IRR
Stockholders Equity Note [Line Items]
Vesting percentage of restricted stock units	100.00%

Summary of Restricted Stock Act

Summary of Restricted Stock Activity (Detail) - Restricted Stock	9 Months Ended
	Sep. 30, 2020$ / sharesshares
Shares of Restricted Stock
Shares of Restricted Stock, Beginning balance | shares	783,823
Shares of Restricted Stock, Granted | shares	1,045,885
Shares of Restricted Stock, Vested | shares	(326,281)
Shares of Restricted Stock, Forfeited | shares	(56,133)
Shares of Restricted Stock, Ending balance | shares	1,447,294
Shares of Restricted Stock, Unvested restricted stock | shares	1,447,294
Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value Outstanding, Beginning | $ / shares	$ 37.53
Weighted Average Grant Date Fair Value, Granted | $ / shares	18.35
Weighted Average Grant Date Fair Value, Vested | $ / shares	35.63
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	33.63
Weighted Average Grant Date Fair Value Outstanding, Ending | $ / shares	24.25
Weighted Average Grant Date Fair Value, Unvested restricted stock | $ / shares	$ 24.25

Summary of Restricted Stock and

Summary of Restricted Stock and Restricted Stock Unit Award Activity (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of restricted stock unit awards that vested during the period	326,281
Fair value of restricted shares that vested during the period	$ 8,944	$ 7,630
Compensation expense recognized during the period	8,235	7,456
Income tax benefit recognized upon vesting of restricted stock awards	$ 2,678	$ 1,473
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of restricted stock unit awards that vested during the period	120,293	88,074
Fair value of restricted shares that vested during the period	$ 3,669	$ 3,550
Accumulated dividends paid upon vesting of restricted stock unit awards	576	375
Compensation expense recognized during the period	4,624	3,030
Income tax benefit recognized upon vesting of restricted stock awards	$ 215	$ 175

Summary of Potential Number of

Summary of Potential Number of Shares that Could Vest Under Restricted Stock Unit Awards (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2020USD ($)shares
Disclosure Of Restricted Stock Unit [Abstract]
Number of shares vesting at IRR of at least 6% | shares	190,707
Number of shares vesting at IRR of at least 8% | shares	286,060
Number of shares vesting at IRR of at least 14% | shares	436,681
Value at grant at IRR of at least 6% | $	$ 6,125
Value at grant at IRR of at least 8% | $	9,188
Value at grant at IRR of at least 14% | $	$ 14,026

Summary of Goodwill (Detail)

Summary of Goodwill (Detail) - USD ($) $ in Thousands		3 Months Ended	9 Months Ended
		Sep. 30, 2020	Sep. 30, 2020
Goodwill [Line Items]
Beginning Balance	[1]		$ 1,283,371
Impairment	[2]		(16,128)
Foreign currency translation adjustments			(17,816)
Ending Balance		$ 1,249,427	1,249,427
U.S. Operating Segment
Goodwill [Line Items]
Beginning Balance	[1]		1,182,853
Ending Balance		1,182,853	1,182,853
International Operating Segment
Goodwill [Line Items]
Beginning Balance	[1]		100,518
Impairment		(16,128)	(16,128)	[2]
Foreign currency translation adjustments			(17,816)
Ending Balance		$ 66,574	$ 66,574
[1]	Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.
[2]	See Note 13 for discussion of impairment evaluations performed during the nine months ended September 30, 2020.

Summary of Goodwill (Parentheti

Summary of Goodwill (Parenthetical) (Detail) $ in Thousands	Sep. 30, 2020USD ($)
U.S. Operating Segment
Goodwill [Line Items]
Accumulated impairment losses	$ 214,031
International Operating Segment
Goodwill [Line Items]
Accumulated impairment losses	$ 27,622

Intangible Assets (Detail)

Intangible Assets (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2020USD ($)
Intangible Assets Net Excluding Goodwill [Abstract]
Intangible assets with finite lives, Beginning balance	$ 85,007
Other, Gross carrying amount	(2,018)
Intangible assets with finite lives, Ending balance	82,989
Intangible assets with finite lives, Accumulated amortization, Beginning balance	(63,924)
Accumulated amortization	(3,569)
Other Accumulated Amortization of Intangible Assets	0
Intangible assets with finite lives, Accumulated amortization, Ending balance	(67,493)
Net intangible assets with finite lives, Beginning balance	21,083
Amortization, intangible assets	(3,569)
Other, Finite lived intangible assets	(2,018)
Net intangible assets with finite lives, Ending balance	15,496
Indefinite-lived Intangible Assets, Tradename and Other, Beginning Balance	300,686
Other, Tradename and Other	(613)
Indefinite-lived Intangible Assets, Tradename and Other, Ending Balance	300,073
Total intangible assets - net, Beginning balance	321,769
Other, Total intangible assets - net	(2,631)
Total intangible assets - net, Ending balance	$ 315,569

Estimated Aggregate Future Amor

Estimated Aggregate Future Amortization Expense for Intangible Assets (Detail) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Finite Lived Intangible Assets Net [Abstract]
For the three months ended December 31, 2020	$ 1,373
For the twelve months ended December 31, 2021	2,765
For the twelve months ended December 31, 2022	2,612
For the twelve months ended December 31, 2023	2,514
For the twelve months ended December 31, 2024	2,514
Thereafter	3,718
Total	$ 15,496	$ 21,083

Summary of Long Lived Asset Imp

Summary of Long Lived Asset Impairment Evaluations Performed by Assets Classification (Detail)	3 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020
Goodwill
Impaired Long-Lived Assets Held and Used [Line Items]
Long lived assets imapirement, Valuation Multiple		N/A
Goodwill | Market Approach
Impaired Long-Lived Assets Held and Used [Line Items]
Long lived assets imapirement, Valuation Multiple	2.9 to 7 times		8 times
Tradename Intangible Assets
Impaired Long-Lived Assets Held and Used [Line Items]
Long lived assets imapirement, Valuation Multiple		N/A
Tradename Intangible Assets | Income Approach
Impaired Long-Lived Assets Held and Used [Line Items]
Long lived assets imapirement, Valuation Multiple	N/A		N/A
Other long-lived assets
Impaired Long-Lived Assets Held and Used [Line Items]
Long lived assets imapirement, Valuation Multiple		N/A
Other long-lived assets | Market Approach
Impaired Long-Lived Assets Held and Used [Line Items]
Long lived assets imapirement, Valuation Multiple	3.2 to 6 times		6 times

Summary of Impairment Charges (

Summary of Impairment Charges (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020		Sep. 30, 2019
Impaired Long-Lived Assets Held and Used [Line Items]
Goodwill	[1]			$ 16,128
Total Impairment		$ 24,595	$ 27,304	41,214		$ 45,382
U.S. Operating Segment
Impaired Long-Lived Assets Held and Used [Line Items]
Theatre properties		2,075	24,502	5,718		26,754
Theatre operating lease right-of-use assets		1,123	2,157	7,075		10,204
Cost method investment		2,500		2,500
Total Impairment		5,698	26,659	15,293		36,958
International Operating Segment
Impaired Long-Lived Assets Held and Used [Line Items]
Theatre properties		938	645	5,422		6,796
Theatre operating lease right-of-use assets		1,654		4,194		1,628
Goodwill		16,128		16,128	[1]
Intangible assets		177		177
Total Impairment		$ 18,897	$ 645	$ 25,921		$ 8,424
[1]	See Note 13 for discussion of impairment evaluations performed during the nine months ended September 30, 2020.

Summary of Liabilities Measured

Summary of Liabilities Measured at Fair Value on a Recurring Basis (Detail) - Fair Value Measurements, Recurring - USD ($) $ in Thousands		Sep. 30, 2020	Dec. 31, 2019
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Interest rate swap liabilities	[1]	$ 36,484	$ 15,995
Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Interest rate swap liabilities	[1]	$ 36,484	$ 15,995
[1]	See further discussion of interest rate swaps at Note 7

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2020USD ($)
Fair Value Disclosures [Abstract]
Fair value of assets transfers in or out, level 1 to level 2	$ 0
Fair value of assets transfers in or out, level 2 to level 1	0
Fair value, asset transfers into Level 3	0
Fair value, asset transfers out of Level 3	$ 0

Foreign Currency Translation -

Foreign Currency Translation - Additional Information (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Foreign Currency [Abstract]
Accumulated other comprehensive income (loss)	$ 414,398	$ 340,112
Cumulative foreign currency losses	$ 390,881	$ 328,053
Cumulative inflation rate	100.00%
Cumulative inflation period	3 years

Summary of Impact of Translatin

Summary of Impact of Translating Financial Statements of Company's International Subsidiaries (Detail) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2019USD ($)	Dec. 31, 2019
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)	$ (1,503)	$ (25,408)	$ (62,830)	$ (19,728)
International Subsidiaries | Cinemark Holdings, Inc. Stockholders' Equity
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)			$ (62,830)	(19,728)
Brazil
Foreign Currency Translation [Line Items]
Exchange Rate	5.63		5.63		4.02
Other comprehensive Income (Loss)			$ (51,453)	(14,492)
Chile
Foreign Currency Translation [Line Items]
Exchange Rate	785.93		785.93		736.86
Other comprehensive Income (Loss)			$ (5,046)	(4,017)
Colombia
Foreign Currency Translation [Line Items]
Exchange Rate	3,878.95		3,878.95		3,277.14
Other comprehensive Income (Loss)			$ (2,584)	(1,507)
Peru
Foreign Currency Translation [Line Items]
Exchange Rate	3.62		3.62		3.37
Other comprehensive Income (Loss)			$ (3,187)	(203)
Other foreign countries
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)			$ (560)	$ 491

Summary of Impact of Translat_2

Summary of Impact of Translating Financial Statements of Company's International Subsidiaries (Parenthetical) (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Foreign Currency Translation [Line Items]
Foreign currency exchange loss	$ (2,251)	$ (4,406)	$ (6,183)	$ (4,785)
Argentina
Foreign Currency Translation [Line Items]
Foreign currency exchange loss			$ 1,053	$ 3,356

Supplemental Information to Con

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail) - USD ($) $ in Thousands

3 Months Ended

9 Months Ended

Sep. 30, 2020

Mar. 31, 2020

[2]

Sep. 30, 2019

Jun. 30, 2019

[2]

Mar. 31, 2019

[2]

Sep. 30, 2020

Sep. 30, 2019

Schedule Of Cash Flow Supplemental [Line Items]

Cash paid for interest

$ 53,364

$ 56,326

Cash paid (refunds received) for income taxes, net

(108,776)

69,498

Noncash investing and financing activities:

Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment

[1]

(7,933)

(13,642)

Investment in NCM – receipt of common units (see Note 9)

3,620

1,552

Dividends accrued on unvested restricted stock unit awards

$ (256)

$ (189)

[2]

$ (189)

$ (108)

(257)

(486)

NCM

Noncash investing and financing activities:

Interest expense - NCM (see Note 9)

$ (5,901)

$ (4,666)

$ (17,726)

$ (14,180)

[1]

Additions to theatre properties and equipment included in accounts payable as of September 30, 2020 and December 31, 2019 were $7,058 and $14,991, respectively.

[2]

Below is a summary of dividends paid to stockholders as well as dividends accrued on unvested restricted stock units during the nine months ended September 30, 2020 and 2019

Supplemental Information to C_2

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Parenthetical) (Detail) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Supplemental Cash Flow Elements [Abstract]
Additions to theatre properties and equipment included in accounts payable	$ 7,058	$ 14,991

Selected Financial Information

Selected Financial Information by Reportable Operating Segment (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Segment Reporting Information [Line Items]
Revenues		$ 35,478	$ 821,817	$ 588,068	$ 2,494,296
Adjusted EBITDA		(127,999)	169,758	(179,406)	566,750
Capital expenditures		20,659	71,343	67,618	186,512
U.S. Operating Segment
Segment Reporting Information [Line Items]
Revenues	[1]	34,409	633,045	470,007	1,930,787
International Operating Segment
Segment Reporting Information [Line Items]
Revenues		1,069	188,772	118,061	563,509
Operating Segments | U.S. Operating Segment
Segment Reporting Information [Line Items]
Revenues		34,639	636,628	472,096	1,941,545
Adjusted EBITDA		(105,767)	132,347	(145,947)	453,404
Capital expenditures		17,903	50,679	54,604	148,609
Operating Segments | International Operating Segment
Segment Reporting Information [Line Items]
Revenues		1,069	188,772	118,061	563,509
Adjusted EBITDA		(22,232)	37,411	(33,459)	113,346
Capital expenditures		2,756	20,664	13,014	37,903
Eliminations
Segment Reporting Information [Line Items]
Revenues		$ (230)	$ (3,583)	$ (2,089)	$ (10,758)
[1]	U.S. segment revenues include eliminations of intercompany transactions with the international operating segment.  See Note 17 for additional information on intercompany eliminations.

Reconciliation of Net Income (L

Reconciliation of Net Income (Loss) to Adjusted EBITDA (Detail) - USD ($) $ in Thousands		3 Months Ended						9 Months Ended
		Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019
Segment Reporting Information [Line Items]
Net income (loss)		$ (148,036)	$ (170,816)	$ (59,422)	$ 31,955	$ 101,861	$ 33,193	$ (378,274)	$ 167,009
Add (deduct):
Income taxes		(121,145)			14,053			(222,398)	64,152
Interest expense	[1]	36,577			24,967			92,284	75,037
Other (income) expense, net	[2]	22,881			(9,970)			47,385	(25,079)
Cash distributions and other cash distributions from equity investees								25,430	28,163
Depreciation and amortization		62,543			67,760			191,380	196,795
Impairment of long-lived assets		24,595			27,304			41,214	45,382
Restructuring costs		524						20,062
(Gain) loss on disposal of assets and other		(13,327)			2,453			(10,997)	8,057
Non-cash rent expense		816			(1,102)			1,649	(3,252)
Share based awards compensation expense		4,427			3,840			12,859	10,486
Adjusted EBITDA		(127,999)			169,758			(179,406)	566,750
Digital Cinema Implementation Partners
Add (deduct):
Cash distributions and other cash distributions from equity investees	[3]				2,694			10,383	7,912
Other Investees
Add (deduct):
Cash distributions and other cash distributions from equity investees	[4]	$ 2,146			$ 5,804			$ 15,047	$ 20,251
[1]	Includes amortization of debt issue costs and amortization of accumulated losses for amended swap agreements.
[2]	Includes interest income, foreign currency exchange gain (loss), equity in income of affiliates and interest expense - NCM and excludes distributions from NCM.
[3]	See discussion of cash distributions from DCIP, which were recorded as a reduction of the Company’s investment in DCIP, at Note 10. These distributions are reported entirely within the U.S. operating segment.
[4]	Includes cash distributions received from equity investees, other than those from DCIP noted above, that were recorded as a reduction of the respective investment balances (see Notes 9 and 10).  These distributions are reported entirely within the U.S. operating segment.

Selected Financial Informatio_2

Selected Financial Information by Geographic Area (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ 35,478	$ 821,817	$ 588,068	$ 2,494,296
Theatre Properties and Equipment - net	1,545,823		1,545,823		$ 1,735,247
Reportable Geographical Components | U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	34,639	636,628	472,096	1,941,545
Theatre Properties and Equipment - net	1,324,924		1,324,924		1,436,275
Reportable Geographical Components | Brazil
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	513	79,776	53,829	240,263
Theatre Properties and Equipment - net	71,338		71,338		118,367
Reportable Geographical Components | Other international countries
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	556	108,996	64,232	323,246
Theatre Properties and Equipment - net	149,561		149,561		$ 180,605
Eliminations
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ (230)	$ (3,583)	$ (2,089)	$ (10,758)

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2020USD ($)TheatreFacilityLease	Sep. 30, 2019USD ($)
Related Party Transaction [Line Items]
Number of leases with minimum annual rent to be paid back | Lease	4
FE Concepts, LLC
Related Party Transaction [Line Items]
Management fee revenues	$ 19,000
Percentage of voting interest	50.00%
Laredo Theatre, Ltd
Related Party Transaction [Line Items]
Company's interest in Laredo	75.00%
Lone Star Theatre's interest in Laredo	25.00%
Ownership interest held by David Roberts	100.00%
Percentage of common stock held by Chairman of the Board of Directors	8.00%
Percentage of management fees based on theatre revenues	5.00%
Maximum amount of theater revenue used to calculate management fees	$ 50,000,000
Percentage of management fees based on theatre revenues in excess	3.00%
Minimum amount of theater revenue used to calculate management fees	$ 50,000,000
Management fee revenues	123,000	$ 539,000
Copper Beech Capital LLC
Related Party Transaction [Line Items]
Amount paid for the use of aircraft	$ 12,000	111,000
Syufy Enterprises, LP
Related Party Transaction [Line Items]
Number of theatres leased | Theatre	14
Number of parking facilities leased | Facility	1
Total number of leases | Lease	15
Number of leases with minimum annual rent | Lease	14
Number of leases without minimum annual rent | Lease	1
Total rent paid to Syufy	$ 17,271,000	$ 20,006,000